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Abstract 
 
Tissue engineering is a field that aims to replace or repair damaged tissue 
through the use of stem cells, biomaterials, and biomolecules.  Human mesenchymal 
stem cells are multipotent adult stem cells that can be autologously transplanted.  This 
work describes the effect of mechanical cues on human mesenchymal stem cells.  An 
analysis on the age-related stiffening of these cells, and its effect on osteogenic and 
myogenic differentiation, is presented.  This study gives insight to those using stem 
cells in vitro for extended periods of time.  The effect of mechanical loading on stem 
cell differentiation is examined.  Tensile and compressive loading are used to induce 
myogenic and osteogenic differentiation, respectively, in the absence of chemical cues.  
This study demonstrates that loading alone can accelerate differentiation.  A 3-D cell 
culture method for cardiomyocyte differentiation is also explored.  Numerous 
cardiomyocyte markers were observed, signifying that this method may be superior to 
chemical induction methods.  A biodegradation study of four porous polymers is also 
presented, as scaffold choice is of great importance in the area of tissue engineering.  
This research provides guidance to those using human mesenchymal stem cells for 
tissue engineering. 
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Chapter 1: Introduction 
 
1.1 Introduction to Tissue Engineering 
The goal of tissue engineering is to replace or regenerate damaged tissue.  This 
field combines stem cells, biomaterials, and biochemical factors.  The stem cell type 
should be easy to obtain, expandable in culture, and should not cause an inflammatory 
response when implanted in vivo.  There are three main classes of stem cells: embryonic 
stem cells (ESCs), induced pluripotent stem cells (iPSCs) and adult stem cells.  ESCs 
are derived from the inner cell mass of a blastocyst.  ECSs are not autologous, and 
therefore could elicit an immune response.  ESCs are able to differentiate into all three 
germ layers [1,2], but are not easily obtained and have ethical concerns surrounding 
them.  iPSCs are adult cells that have been reprogrammed using genetic engineering 
techniques [3].  The main concern with iPSCs is the risk of tumor formation after 
implantantion [4].  Adult stem cells include hematopoietic stem cells, which give rise to 
the blood cell lines [5], and mesenchymal stem cells (MSCs), which can differentiate 
into various lineages [6-18].  MSCs are of particular interest because of their relative 
ease of isolation, lack of ethical concern, and potential for autologous transplant.   
MSCs are found in bone marrow [19], umbilical cord blood [20], adipose tissue 
[21], and other various tissues (Figure 1), although bone marrow MSCs are the most 
widely studied.  MSCs classically differentiate into lineages from the mesoderm (bone, 
cartilage, fat, tendon, muscle), but may also be able to transdifferentiate into cells from 
other germ layers, including neurons [6-18].  By definition of the International Society 
of Cellular Therapy, MSCs are adherent cells that positively express cell surface 
3 
 
markers CD73 (SH2), CD90, and CD105 (SH3) and negatively express CD34, CD45, 
CD14 or CD11b, CD79α, or CD19 and HLA-DR, and are able to differentiate into 
osteoblasts, adipocytes, and chondrocytes [22].  While human MSCs (hMSCs) have the 
advantage that they can be autologously transplanted, they are also a potential candidate 
for safe allogenic transplant due to their immunosuppresive properties.  Specifically, 
they lack the surface expression of human leukocyte antigen (HLA) class II molecules 
and the expression of costimulatory molecules for T cell induction (CD40, CD40 
ligand, and the B7 molecules CD80 and CD86) [23].   
 
 
Figure 1: Isolation sites and lineages of MSCs [24] 
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hMSCs have been used in clinical trials for a variety of conditions, including 
osteogenesis imperfecta [25], cartilage repair [26], large bone defect [27], and 
improvement of cardiac function after a heart attack [28].  However, it is unclear 
whether the improvement of various conditions is due to differentiation after 
implantation, cell fusion, or the bioactive molecules secreted by hMSCs (which can 
stimulate angiogenesis and inhibit apoptosis), or a combination of these factors [29,30].  
While the method of repair in vivo remains to be elucidated, it is apparent that hMSCs 
are of large significance to the tissue engineering field.   
Besides cell choice, another important factor of tissue engineering is material 
choice.  Stem cells can be grown on a natural or synthetic scaffold in vitro and then 
implanted in the body [31].  While cells can also be injected, a scaffold provides 
mechanical support for the cells.  If a scaffold is chosen, it must be biodegradable and 
biocompatible. Common scaffold production methods include solvent 
casting/particulate leaching [32], electrospinning [33], and thermally induced phase 
separation [34].  Porous scaffolds have benefits over nonporous, as pores allow cell 
ingrowth and a 3-D environment.  The mechanical properties and topographical features 
of the scaffold are of great importance, as cells can “feel” the substrate or extracellular 
matrix on which they reside [35].   
1.2 Introduction to Mechanotransduction 
The process by which cells sense and respond to mechanical signals is called 
mechanotransduction [36].  The cell’s key players of mechanotransduction are the 
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extracellular matrix (ECM), cytoskeleton, transmembrane integrin receptors, and 
signaling molecules [37,38].  The ECM provides support for cells and is comprised of 
various proteins, including fibronectin, collagen, laminin, hyaluronic acid, and 
numerous proteoglycans [39].  The cytoskeleton is made up of actin filaments, 
intermediate filaments, and microtubules, and is responsible for cell shape, motility, 
division, and intracellular trafficking.  Integrins are a family of heterodimers comprised 
of α and β subunits.  There are at least 18 α and 8 β subunits, which can produce 24 
different heterodimers, each of which binds to specific ligands [40].  Cells attach to 
substrates by forming focal adhesions, where integrins cluster and attach to actin 
filaments by proteins such as talin, tensin, and vinculin (Figure 2) [41].   
 
 
 
 
Figure 2: Schematic of the nanoscale architecture of a focal adhesion [42] 
 
In vitro, mechanical cues can direct many aspects of cell function, including cell 
migration [43-45], proliferation [46], the regulation of disease states [37], and stem cell 
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differentiation [47,48].  One cue that can direct cells is substrate stiffness, which has 
been shown to dictate differentiation, functionality, and the cells’ own mechanical 
properties.  Engler et al. showed that myoblasts and cardiomyocytes organize and 
function optimally on substrates that have similar elasticity to their native tissue [47,49].  
Engler et al. also differentiated hMSCs into neurogenic, myogenic, and osteogenic cells 
solely based on matrix stiffness [48].  However, it should be noted that differentiation 
also depends on ligand presentation.  hMSCs were able to differentiate into osteoblasts 
on stiff polyacrylamide gels (80 kPa) when they were coated with collagen 1 (the main 
collagen type present in bone), but not with collagen IV, fibronectin, or laminin [50].  In 
opposition to stiffness-mediated differentiation, MSCs were able to remain quiescent on 
substrates with a stiffness that mimics bone marrow (250 Pa) [51].  Additionally, the 
mechanical properties of cells can also be modulated by the substrate.   hMSCs 
exhibited lower elastic modulus values when grown on polydimethylsiloxane (PDMS) 
(E≈3 MPa) vs. TCPS (E≈2 GPa) [52]. 
 Another mechanical cue that can be used to direct stem cell differentiation and 
alignment is topography at the nano- and micro-scale.  hMSCs were grown on PDMS 
with microprinted collagen I features in both square and rectangular shapes.  It was 
found that not only did the rectangular collagen I features elongate the cells, but they 
also caused the upregulation of myogenic markers (as muscle cells are typically 
elongated) [53].  At the nano-scale, Yim et al. used 350nm gratings on PDMS to align 
and stimulate neuronal differentiation of hMSCs.  The expression of neuronal markers 
was higher in the cells on the nano-features compared to chemical induction on 
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unpatterned surfaces [54].  Therefore, both nano- and micro-sized features can guide 
hMSCs.  
 Differentiation can also be controlled by cell shape, which is modulated by 
cytoskeletal tension.  hMSCs in mixed adipogenic/osteogenic media that are confined to 
a round shape by micropatterned fibronectin displayed lipid droplets (a marker of 
adipocytes).  On the other hand, hMSCs that were able to spread on larger, square 
patterns and form stress fibers displayed alkaline phosphatase, a marker of osteoblasts 
[55].  Additionally, hMSCs were more likely to exhibit an adipogenic phenotype on 
micropatterns with rounded edges (flower shape) and an osteoblastic phenotype on a 
micropattern with straight edges (star shape) when grown in mixed 
osteogenic/adipogenic media, due to differences in cytoskeletal tension [56].  The 
impact of cell shape in differentiation is largely controlled by the Rho GTPase RhoA, as 
a rounded cell decreases RhoA and induces adipogeneis, while a spread cell increases 
RhoA and induces osteogenesis [55].  Gao et al. examined the effect of transforming 
growth factor β (TGF-β) (which can induce both chondrogenesis and myogenesis) and 
cell shape on hMSC differentiation.  Cells on round micropatterns upregulated a 
chondrogenic marker, collagen II.  Conversely, cells on larger, square micropatterns, as 
well as cells on unpatterned surfaces, were allowed to spread and upregulated a smooth 
muscle marker, calponin (Figure 3) [57].  These studies demonstrate the effect of cell 
shape on lineage determination between adipogenesis, chondrogenesis, osteogenesis, or 
myogenesis in hMSCs.     
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Figure 3: Expression of myogenic marker, calponin, when confined to a square 
shape, and to a higher degree, when allowed to spread and elongate.  Conversely, a 
chondrogenic marker, collagen II, was expressed when cells were confined to a 
round shape [57] 
 
The Rho GTPases play a large role in cell signaling and cytoskeleton 
arrangement.  Of the Rho GTPases, Cdc42, Rac1, and RhoA are the most widely 
studied.  Cdc42 affects filopodia (small cell projections), Rac1 controls lamellopodia 
(projections at the leading edge of the cell), and RhoA controls stress fibers (bundles of 
actin) [58].  These Rho GTPases seem to play large roles in the lineage specification of 
MSCs (Figure 4).  As previously mentioned, Rho may play a role in the 
adipogenesis/myogenesis cell fate decision, as reduced Rho activity leads to 
adipogenesis, while increased Rho activity leads to myogenesis [55,59].  RhoA’s 
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downstream effector Rho Kinase (Rock) mediates cytoskeletal tension, and was shown 
to induce osteogenesis in hMSCs independent of cell shape [55].  Additionally, Rac1, 
which tends to oppose the action of RhoA, has been implicated in chondrogenesis and 
adipogenesis [57,60].  In conclusion, Rho, Rac1, and Rock mediate cell fate in MSCs. 
 
 
 
Figure 4: Involvement of Rho GTPases in MSC lineage determination [61] 
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1.3 Systems for biomechanical measurements 
Many systems have been developed for measurements of cellular mechanical 
properties, including optical tweezers [62], micropipette aspiration [63], and atomic 
force microscopy (AFM) [64].  The chosen method depends on the amount of force and 
deformation required, the type of cell, and level of force application (cell population, 
single cell, or single molecule).  Further, the chosen model depends on the technique 
and the cell type, i.e. some techniques/models are better suited for nonadherent cells, 
such as erythrocytes, as opposed to adherent cells.  Models for cell mechanics are 
generally grouped as continuum models or micro/nano-structural models.  Examples of 
continuum models are elastic and viscoelastic solid models.  On the other hand, an 
example of a micro/nano-structural model is tensegrity, where actin filaments and 
intermediate filaments are assumed to be in tension, and microtubules oppose 
compressive forces [65].  The methods and models most relevant to hMSCs are 
discussed below.   
Micropipette aspiration is a technique used to measure time-dependent 
deformation of living cells [63].  A cell is pulled into a micropipette and the extension 
of the cell is measured by optical microscopy (Figure 5).  The diameter of the glass tube 
is chosen relative to the cell size and the applied pressure can range from 0.1-1000 Pa.  
The force (F) can be calculated, using the pressure, radius of the micropipette, and the 
velocities of the cells in the presence and absence of pressure. Micropipette aspiration 
has the benefits of loading an entire cell and eliminating the cell-matrix interactions.  
Both linear elastic and viscoelastic solid models have been applied to micropipette 
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aspiration.  A linear elastic solid model neglects the time factor, and can be modeled as 
a spring, by the equation: 
                                           (1) 
Where σ is the applied stress, ε is the resulting strain, and E is the elastic modulus.  
When the micropipette radius is much smaller than the radius of the cell, the cell can be 
considered an incompressible half space, and the projection length is: 
                                                           
     
   
                                                     (2) 
Where G is the shear modulus and Φp is a function of the pipette geometry (wall 
thickness and radius) [66].   
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Figure 5: Micropipette aspiration of hMSCs at A) 1s, B) 15s, C) 100s, and D) 200s 
[67]. 
 
However, a linear elastic model is generally inadequate to describe cell 
mechanics and a viscoelastic model may be a more suitable choice, as cells are 
inherently viscoelastic.  A homogeneous viscoelastic standard linear solid model was 
proposed to study the response of human leukocytes to micropipette aspiration [68].  It 
is modeled as a spring and dashpot in series that are parallel to another spring (Figure 
6). 
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Figure 6: Homogenous standard linear solid model can be applied to a cell [69] 
 
This model has the constitutive equation: 
                                    
  
  
 
  
 
 
 
  
  
  
       
     
                                                  (3) 
Where k1 and k2 are elastic constants, and η is a viscous constant.  The creep 
compliance is given by: 
                                              
 
     
  
  
  
 
 
     
      
 
                                (4) 
The exponential time constant is: 
                                                          
        
    
                                                          (5) 
Using the following substitution relating creep compliance and shear modulus, the 
aspiration length using the standard linear solid model can be derived from the elastic 
solution: 
                                                                   
 
  
                                                           (6) 
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                                             (7) 
The instantaneous Young’s modulus (E0) and equilibrium Young’s modulus (E∞) can be 
calculated as: 
                                                  
 
 
                                                             (8) 
                                                        
 
 
                                                              (9) 
 
Besides the standard linear solid model, various liquid drop models have also been 
applied to micropipette aspiration.  These models represent the cell membrane as a shell 
and the cytoplasm as a viscous liquid [70].  Liquid drop models are most appropriate for 
cells that demonstrate liquid behavior (i.e. leukocytes, neutrophils) [63].  While 
micropipette aspiration is a tool commonly used for non-adherent cells, it may also be 
used to determine the mechanical properties of adherent cells in suspension.  
AFM is a technique that can be used to indent living cells with pN forces.  It is 
reviewed in great detail in Section 2.3.2.  In general, values of elastic modulus are 
found to be higher with AFM compared to micropipette aspiration.  For example, 
reported modulus values of hMSCs with AFM are 1-40 kPa [71-73] and <1 kPa with 
micropipette aspiration [74].  The AFM also determines local cell properties (and 
underlying effects of the nucleus, stress fibers, etc.), while micropipette aspiration 
reflects whole cell properties in a suspended state.  The Hertz elastic contact model is 
frequently used to find the elastic modulus of a cell, and is based on indenter radius (R), 
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force applied (F), indentation depth (δ), and Poission’s ratio (ν) (assumed to be 0.5 for 
cells) [75]: 
                                            
   
 
   
       
                                                        (10) 
The classical model relates the indentation of two spheres, but this model has 
also been extended to indenters of conical shapes (where α is the half opening angle of 
the tip) [76]: 
                                                      
        
       
                                                      (11) 
 
While this model makes many assumptions which are not valid for cells (isotropic, 
linearly elastic, and infinitely deep), it fits well at small deformations.  However, 
precautions must be taken when using this model.  The sample indentation should be 
<10% to neglect the effect of the cell substrate [77] and slow indentation speeds (<10 
um/s) should be utilized to minimize viscous effects [78].  Variations of the Hertz 
model have been created for different cell shapes [79] and for thin samples [80].  While 
the elastic Hertz model may not be entirely suitable for cells, some improvements have 
been made to account for cell shape and height. 
 A viscoelastic solution to the Hertz model has also been derived, assuming small 
indentations of an isotropic, incompressible surface by a hard, spherical indenter [81]: 
                                   
       
 
 
      
   
     
  
 
 
 
                                         (12) 
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Where ER is the relaxed modulus, τσ is the time of relaxation of deformation under 
constant load, and τε is time of relaxation of load under constant deformation.  Darling et 
al. performed 60 s relaxation tests on cells, and applied the Hertz model to the approach 
to determine the elastic behavior and the above equation to the relaxation data to 
determine the viscoelastic behavior.  Fitting the above equation to the force-
displacement curve provides three parameters that describe a standard linear solid 
viscoelastic model (Figure 6), where k1 and k2 are elastic constants and η is a viscous 
constant: 
                                                                                                                              (13) 
                                                                
     
  
                                                   (14) 
                                                                                                                      (15) 
The instantaneous modulus (E0) and Young’s modulus (EY) can then be calculated: 
                                                               
     
  
                                               (16) 
                                                                  
 
 
                                                         (17) 
Therefore, the viscoelastic behavior of cells can be found by AFM using the appropriate 
tests and model.    
 Optical tweezers are a tool that uses a laser beam with an objective lens of high 
numerical aperture to apply forces to cells [82].  This method was used to determine the 
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membrane tether length in hMSCs [83].  Fluorescent polystyrene beads (diameter=0.5 
µm) were attached to cells using an anti-CD29 (MSC cell surface marker) antibody.  An 
elastic spring equation was used to determine the force applied to the bead by the 
optical tweezers: 
                                                                                                                            (18) 
where k is the stiffness of the optical tweezers and x is the displacement of the bead.  
The bead was pulled from the membrane until the bead escaped, and the tether length 
and escape force were recorded.  The average tether length and escape force for hMSCs 
was 10.6±1.1 µm and 9.7±0.7 pN, compared to 3.0±0.5 µm and 8.8±0.5 pN for 
fibroblasts, respectively.  This difference was attributed to increased membrane 
reservoir in hMSCs [83].  Suspended hMSCs were also examined using optical 
stretching, a variation of optical tweezers (Figure 7) [71].  The best fit was found with 
the offset power law (compared to 3 and 4 element viscoelastic models): 
                                                                        (19) 
                                                      
                                           (20) 
where cells were stretched from t0 to t1, and allowed to recover until t2.  A and C are 
fitted prefactors, B is the offset constant, and aS and aR are the exponents for stretching 
and recovery, respectively.  Results show that hMSCs exhibit power law rheology 
during both stretching and recovery, where A, B, and C were 3.45, -1.32, and 0.79, 
respectively.  The stretching and recovery could be described by a single exponent, aS 
and aR = 0.256.  Interestingly, this study showed that while differences in mechanical 
properties (increased elastic modulus) were observed during extended passaging in 
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adherent cells, no changes in creep behavior were observed in suspended cells during 
extended passaging [71].   
 
Figure 7: Optical stretching of hMSCs (left).  Deformation during stretching and 
recovery (right) [71]. 
 
The use of these techniques has been complemented by the use of reagents to 
disrupt or stabilize components of the cytoskeleton.  For example, cytochalasin D is a 
reagent that disrupts actin fibers.  When hMSCs were treated with 20 µM cytochalasin 
D, instantaneous modulus and elastic modulus decreased by 42–66% and viscosity 
increased by 95%.  This caused a significant increase in aspiration length during 
micropipette aspiration (Figure 8) [67].   Titushkin et al. subjected hMSCs to 
cytochalasin D or nocodazole (which prevents microtubule polymerization), and found 
the elastic modulus using AFM.  The elastic modulus decreased more than 75% when 
actin fibers were disrupted, but no statistically significant difference was observed when 
microtubules were disrupted [72].  Methyl-b-cyclodextrin was used in the 
aforementioned study of hMSC tether length by optical tweezers.  Methyl-b-
19 
 
cyclodextrin depletes cholesterol, which is known to decrease membrane stiffness.  
After treatment, the membrane tether length increased from was 10.6±1.1 µm to 
16.6±1.9 µm [83].  The use of these reagents gives insight into the effect of various 
cytoskeletal components on mechanical properties.   
   
 
 
Figure 8: Micropipette aspiration of hMSCs treated with µM cytochalasin D at at 
A) 1s, B) 15s, C) 100s, and D) 200s.  The disruption of actin filaments causes a 
significant increase in aspiration length compared to control [67]. 
 
 
 
1.4 Outline of Dissertation 
Chapter 2 is an investigation of the change in elastic moduli of hMSCs during in 
vitro aging, and how this change relates to differentiation capacity.  In vitro aging is an 
important subject since hMSCs are routinely cultured for extended periods of time on 
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tissue culture polystyrene (TCPS), and there are currently no standards for this practice.  
This study illustrates the effects of long-term culture on hMSC mechanical properties 
and differentiation.      
Chapter 3 explores the effects of cyclic mechanical loading on hMSC 
differentiation.  Chemical induction is the most common method of hMSC 
differentiation, but mechanical forces may more accurately mimic the in vivo 
environment.  Cells were grown on 3-D porous polymer scaffolds and subjected to 
tensile and compressive loading to stimulate myogenesis and osteogenesis, respectively.  
Results demonstrate that differentiation can be accelerated by short-term loading.    
Chapter 4 describes the use of a 3-D cell culture method for hMSC 
cardiomyocyte differentiation.  In line with the previous chapter, there is a need for 
differentiation methods that do not require chemical induction.  This chapter uses a cell 
aggregation method that can produce aligned cells that express cardiomyogenic 
markers, and may provide a clinical alternative to current methods. 
Chapter 5 is an in vitro biodegradation study of 4 polymers commonly used in 
tissue engineering and biomedical applications.  The study was conducted on 3-D 
porous foams, as there was a lack of knowledge about the effects of porosity on 
biodegradation.  Common polymer characterization methods were used to examine the 
mechanical, thermal, chemical, and morphological characteristics during a 16 week 
period.  Results may be useful to the tissue engineering community that requires 
different degradation time lengths for different applications.   
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Chapter 6 provides a conclusion of the dissertation, which includes a summary 
of the conducted research, as well as a description of future recommended studies. 
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Chapter 2: Effect of In Vitro Aging on Mechanical Properties and Differentiation 
Capacity of Human Mesenchymal Stem Cells 
 
2.1. Chapter Overview 
hMSCs are an attractive cell source for tissue regeneration, given their self-
renewal and multilineage potential.  hMSCs were cultured and routinely passaged on 
TCPS to investigate the correlation between cell stiffening and differentiation capacity 
during in vitro aging.  Local cell elastic modulus was measured at every passage using 
AFM indentation.  At each passage, osteogenic and myogenic differentiations were 
carried out.  Gene and protein expression was examined using quantitative reverse 
transcriptase polymerase chain reaction (qPCR) and immunofluorescent staining, 
respectively, for osteogenic (osteocalcin, osteonectin, osteopontin, alkaline phosphatase, 
Runx2, collagen 1) and myogenic (tropomyosin, sarcomeric actin, smooth muscle α 
actin, β-myosin heavy chain, calponin 1, troponin T, desmin) markers.  Results show 
that the success of myogenic differentiation is highly reliant on the elastic modulus of 
the undifferentiated cells, and peaks when the elastic modulus of the undifferentiated 
cells is closest to that of native muscle.  The success of osteogenic differentiations 
appears to be somewhat dependent on the cell elastic modulus, as differentiations were 
more successful in earlier passages, when cells exhibited a lower endogenous elastic 
modulus.  This is the first study that links the average elastic modulus of a population of 
hMSCs to their differentiation success in long-term culture, as well as the first report of 
myogenic potential during aging.  This study elucidates some of the age-related changes 
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of hMSCs, and provides guidance for those utilizing adult stem cells for tissue 
engineering. 
2.2. Introduction 
       hMSCs are adult stem cells that can differentiate into different lineages, 
including bone, cartilage, fat, tendon, muscle, and possibly neurons [6-18].  They have 
the ability to proliferate in culture while retaining their multilineage potential.  Because 
of their multipotency, hMSCs have great potential for regenerative medicine and tissue 
engineering.  However, MSCs only represent 0.001% to 0.01% of cells in bone marrow 
[84].  To have an adequate amount for therapeutic use, hMSCs must be expanded in 
vitro.   
 TCPS is the standard growth substrate in cell culture laboratories and has an 
elastic modulus is approximately 3 GPa.  This is several orders of magnitude stiffer than 
values for cells, which are typically in the kPa range [71,72,85,86].  Therefore, this 
substrate may not be ideal for stem cell maintenance.  It is known that hMSCs are 
subject to in vitro aging, which is hallmarked by telomere shortening, slowed 
proliferation, and decreased differentiation capacity [71,87-91].  Bonab et al. studied the 
osteogenic and adipogenic differentiation potential of expanded hMSCs.  By the 10th 
passage in vitro, 20% and 60% of the samples lost their osteogenic and adipogenic 
differentiation potential, respectively [87].  Aging in vitro is accompanied by changes in 
the mechanical properties of hMSCs, most likely due to stiff in vitro culture substrates, 
as it has been shown that the elasticity of hMSCs can be modulated by growth substrate 
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[52].  AFM indentation is commonly used to measure the elasticity of live cells 
[64,77,92].  Maloney et al. used AFM to indent hMSCs maintained on TCPS over 17 
population doublings and saw the elastic modulus increase from approximately 2 kPa to 
8 kPa [71].  That study also found that the differentiation potential for both osteogenic 
and adipogenic differentiation reduced between population doublings 4 and 14.  It 
seems evident that cell culture conditions contribute to the in vitro aging effects of cell 
stiffening and decreased differentiation capacity.   
This study examines how differentiation capacity changes with elastic modulus 
of undifferentiated hMSCs in extended culture.  AFM was used to quantify cell elastic 
modulus over many in vitro passages.  At each passage, osteogenic and myogenic 
differentiations were carried out.  While most aging studies have used mineralization 
assays to assess osteogenic differentiation success [10,87,88,90,93,94], this study 
examines the protein and mRNA expression of various lineage-specific markers at each 
passage.  Additionally, the success of myogenic differentiation over various passages 
has not been studied until now.  Our results show that the average elastic modulus of a 
population of hMSCs dictates their osteogenic and myogenic differentiation success in 
extended culture.     
 
2.3.Experimental Details 
2.3.1. Cell culture 
Adult hMSCs (PT-2501, Lonza, Walkersville, MD) were cultivated on TCPS 
dishes in Mesenchymal Stem Cell Basal Medium supplemented with Mesenchymal 
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Stem Cell Growth Media (MSCGM) SingleQuots (Lonza).  When cells reached 70% 
confluency, they were passaged at a 1:6 dilution (approximately 1000 cells/cm
2
).  Cells 
were directed down the osteogenic and myogenic lineages from passage 4 (P4) to P9.  
To induce osteogenic differentiation, hMSCs were incubated in osteoinductive media 
for 4 weeks.  Osteoinductive media contained Dulbecco's Modified Eagle Medium 
(DMEM) Low Glucose with L-glutamine, glucose, and sodium pyruvate (HyClone 
Laboratories, Logan, UT) supplemented with 10% fetal bovine serum (FBS) (HyClone 
Laboratories), 0.1μM dexamethasone (EMD Millipore, Billerica, MA), 10 mM β 
glycerol phosphate (Sigma Aldrich, St. Louis, MO), and 0.05 mM ascorbic acid (Acros 
Organics, Morris Plains, NJ).  To induce myogenic differentiation, 5 mM 5-azacytidine 
(MP Biomedicals, Solon, OH) was added to media (DMEM Low Glucose, 10% FBS) 
once a week for 24 hours.  This procedure was repeated for 4 weeks.   
 
2.3.2. AFM indentation 
The AFM was developed in 1986 [95], and was originally used as a tool to 
characterize the topography of surfaces.  It can also be used for force spectroscopy, to 
measure the mechanical properties of biological specimens and adhesive forces between 
molecules.  The AFM utilizes a cantilever with a tip that can indent or scan surfaces.  A 
piezoelectric translator allows for vertical movement with sub-nanometer resolution.  
The cantilever deflection is measured by focusing a laser on the cantilever.  The light is 
reflected off the cantilever and detected by a photodetector (Figure 9).  The 
photodetector records the voltage as a function of piezoelectric displacement.  Silicon or 
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silicon nitride probes are commonly used.  For indentation of biological samples, probes 
with a spring constant of 10-200 pN/nm are preferred [96]. 
 
Figure 9: Diagram of the AFM [97] 
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Prior to indentation, the optical lever sensitivity and spring constant of the tip 
must be calibrated.  The cantilever sensitivity (C) (m/V) is found by pressing the tip 
onto a hard surface and measuring the slope of the force-distance curve (Figure 10).  A 
typical slope (C) is 1*10
-7
,
 
or 100nm/V. 
 
Figure 10: Cantilever sensitivity 
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The spring constant is calculated by submerging the cantilever in buffer (or other media 
used during force spectroscopy) and finding the thermally induced fluctuation.  To do 
this, a sample scan is recorded (Figure 11).   
 
Figure 11: Sample scan to record thermal fluctuation. 
 
From the sample scan, a power spectral density can be calculated (Figure 12).  The area 
of the spectral density is equal to the mean square displacement of the cantilever.  
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Figure 12: Power spectral density 
 
The equipartition theorem can be applied to equate the elastic potential energy to 
the thermal energy, if it is assumed that cantilever response is linear and with one 
degree of freedom. 
                                                        
    
  
 
 
   
 
                                                      (21) 
The spring constant (kc) can then be calculated, where kb is Boltzmann’s 
constant, T is temperature, and < 2> is the mean square displacement of the cantilever 
[98]: 
                                                               
   
    
                                                          (22) 
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As a cell is indented, the displacement of the cantilever is recorded as a force-distance 
curve (Figure 13).  
 
Figure 13: Force-distance curve recorded during cell indentation. 
 
The force (F) can be calculated through Hooke’s Law (Figure 14), as the cantilever 
behaves as a spring for small deflections (d): 
                                                                                                                             (23) 
The displacement is equal to: 
                                                                                                                            (24) 
where C (m/V) is the cantilever sensitivity and ΔV is the change in voltage. 
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Figure 14: Force-distance curve of approach 
 
The indentation depth (δ) can be found by subtracting the deflection (d) from the 
position of the probe (z) (Figure 15): 
                                                                                                                           (25) 
32 
 
 
Figure 15: Deflection of the cantilever as a sample is indented [99] 
 
The Hertz contact theory can be applied to find the elastic modulus of the indented 
surface [75].  While the classical theory involves two spheres, Sneddon applied the 
Hertz contact theory to conical probes, with the assumptions that the sample is semi-
infinitely large (compared to indenting tip), perfectly flat, homogeneous, linearly 
elastic, and isotropic [76].  For a conical tip, the indentation force equals: 
                                                            
         
 
                                                    (26) 
Where E* is the relative elastic modulus that depends on the elastic moduli and 
Poisson’s ratio (ν) between the indenter and the sample: 
                                                          
 
  
 
    
 
  
 
    
 
  
                                               (27) 
                                                                                                                              (28) 
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                                                         (29) 
Therefore, the force on the sample is equal to: 
                                                             
    
     
      
  
                                                    (30) 
Where E1 and ν1 are the elastic modulus and Poisson’s ratio of the indented sample, 
respectively.  The Poisson’s ratio is generally assumed to be 0.5 for cells, and α is the 
half opening angle of the cone tip. 
2.3.2.1.AFM Experimental Conditions 
AFM indentations were performed on a home-built system (Figure 16).  Local 
cell elastic modulus of undifferentiated cells was measured at every passage from P3 to 
P11 using AFM indentation.  Fully differentiated osteogenic and myogenic cells were 
indented at the most successful passage (P4 and P7, respectively).  A Basal Locke 
Buffer was used during indentation to maintain pH.  Fifty cells were indented per 
passage, and cells were indented in 2 spots (1 on the edge of the cell and 1 in the 
cytoplasm).  Silicon nitride cantilevers (MLCT, Bruker Nano, Camarillo, CA) with a 
nominal tip radius of 20nm were used (Figure 17).   
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Figure 16: Home-built AFM system 
 
 
 
Figure 17: Silicon nitride probe used for cell indentation 
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The spring constants (0.01 N/m) of the calibrated cantilevers agreed with the values 
specified by the manufacturer.  The tip had a half opening angle (α) of 35°.  A 
maximum signal of 500 mV was used.  Typical forces were approximately 500pN: 
                                   
 
 
        
 
 
                             (31) 
The sample rate was 8 kHz.  The elastic moduli were found using the Hertz model, as 
previously discussed.  Data was analyzed with a custom-made program written in 
IgorPro (WaveMetrics, Portland, OR), using a least square analysis. 
 
2.3.3. Actin stress fiber measurements 
The average stress fiber diameter was measured at every passage from P3 to P11 
using fluorescence microscopy.  hMSCs were fixed in 10% formalin and stained with 
rhodamine phalloidin (Cytoskeleton, Inc., Denver, CO) to view actin stress fibers.  The 
images were analyzed using the NIH program, ImageJ.  A line was drawn perpendicular 
to the plane of most stress fibers (Figure 18, top).  The plot profile was used to find the 
diameter of each stress fiber (Figure 18, bottom).  Fifty cells were analyzed for every 
passage.  The experiment was repeated. 
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Figure 18: An hMSC stained with rhodamine phallodin to view stress fibers (top).  
ImageJ was used to find the plot profile (bottom). 
 
2.3.4. Immunocytochemistry 
Immunocyochemistry is a technique that uses antibodies tagged with fluorescent 
molecules to visualize the antigen of interest.  Fixation and immunocytochemical 
processing for osteogenic and myogenic markers was conducted using standard 
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protocols.  Briefly, cells were fixed with 10% formalin in 1 x PBS for 15 minutes. The 
samples were then treated with 100% methanol for 7 minutes.  Non-specific binding 
sites were blocked for 30 minutes with agitation at room temperature with 1% bovine 
serum albumin (BSA).  Primary antibodies were incubated for 1h at 37°C, followed by 
incubation with appropriate secondary antibodies (Alexa Fluor 488, Alexa Fluor 546, 
Alexa Fluor 555, 1:1000, Invitrogen) for 1h at room temperature.  The nuclei were then 
counterstained with Hoechst dye (0.002 mg/ml in 1 x PBS) for 5 minutes.  The 
monoclonal antibodies mouse anti-osteopontin (OP) (MPIIIB10(1), 1:500), developed 
by Michael Solursh and Ahnders Franzen, and anti-osteonectin (ON) (AON-1, 1:500), 
developed by John D. Termine, were obtained from the Developmental Studies 
Hybridoma Bank developed under the auspices of the NICHD and maintained by The 
University of Iowa, Department of Biology, Iowa City, IA 52242.  Phycoerythrin-
conjugated mouse anti-osteocalcin (OC) (1:500) was purchased from R&D 
(Minneapolis, MN). Sheep polyclonal anti-tropomyosin (1:500) was purchased from 
Millipore (Billerica, MA). Mouse monoclonal anti-sarcomeric actin (1:250) was 
purchased from Invitrogen (Carlsbad, CA). 
2.3.5. qPCR 
qPCR a technique that exponentially amplifies target DNA sequences for 
genetic analysis [100].  RNA from the sample of interest is isolated and converted to 
cDNA by reverse transcription.  Short DNA sequences that are complementary to the 
target sequence (“primers”) are used for each gene of interest.  This method uses 
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thermal cycling.  In the first step, the temperature is raised to ~95°C to melt the DNA 
strands (denaturation step).  The temperature is then lowered (~60°C), and primers bind 
to the ends of the target sequence (annealing step).  The third step is extension, where 
DNA polymerase synthesizes new complementary strands.  The temperature of this step 
depends on the DNA polymerase used.  A fluorescent dye that binds to double stranded 
DNA, such as SYBR Green, is used to measure the amount of amplified sequence.  The 
thermal cycling sequence is repeated for approximately 40 cycles, and the fluorescence 
signal is measured after each cycle.  A gene sequence that is present in approximately 
the same amount in all cells is used as a “housekeeping gene.”  Examples of 
housekeeping genes are glyceraldehyde-3-phosphate dehydrogenase (GAPDH), β actin, 
and major histocompatibility complex I.  The amplification curves of each gene of 
interest are compared by setting a threshold value (commonly 20% above the baseline).  
The cycle number at which the amplification curve crosses the threshold is called the 
threshold cycle (Ct) (Figure 19).  
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Figure 19: Typical amplification curve of qPCR 
 
 
qPCR was performed on undifferentiated and differentiated cells from P4 to P9 
to assess mRNA expression.  Total RNA was isolated using RNeasy Plus Micro kits 
(Qiagen, Valencia, CA).  RNA was converted to cDNA using a Qiagen Omniscript RT 
Kit.  Cycles were optimized for the amplicon size and primer Tm on a Qiagen Rotor-
Gene qPCR system.  A SYBR green qPCR kit from Qiagen was used to assess gene 
expression.  Primers can be seen in Table 1. 
Analysis of the qPCR data was completed using the ΔCt method [101], with a 
threshold value of 20% above the background.  Primer efficiency values were 
empirically derived from undifferentiated hMSCs for the housekeeping gene (GAPDH), 
osteogenic hMSCs for bone markers, and myogenic hMSCs for muscle markers.  The 
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copy rate of each primer was found using the slope of the efficiency curve, where r is 
the copy rate and x is the slope: 
                                                      
 
                                                           (32) 
Fold changes were determined through ΔCt comparison, and all data was subject to 
normalization to the housekeeping gene (GAPDH) corresponding to each experimental 
condition and specimen. The ΔCt was calculated using the Cts of both the housekeeping 
gene (HKG) and the gene of interest (GOI): 
                                                                                                                      (33) 
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Table 1: qPCR primers 
 
Target/control 
gene 
Primer Sequence (5’-3’) Amplicon 
Size 
Melting  
Temperatures 
GAPDH  F- CGGATTTGGTCGTATTGG  
R- TCAAAGGTGGAGGAGTGG  
861 F Tm = 53.2 
R Tm = 55.7 
Collagen 1 
(Col 1) 
 
F- ATCCAGCTGACCTTCCTGCG 
R- TCGAAGCCGAATTCCTGGTCT 
323 F Tm = 62.3 
R Tm = 61.5 
Runx2  F- CCACCCGGCCGAACTGGTCC  
R- CCTCGTCCGCTCCGGCCCACA 
258 F Tm = 67.7 
R Tm = 71.1 
Osteocalcin 
(OC) 
F- GAAGCCCAGCGGTGCA 
R- CACTACCTCGCTGCCCTCC 
70 F Tm = 60.0 
R Tm = 62.1 
Alkaline 
Phosphatase 
(ALP) 
F- ACGTGGCTAAGAATGTCATC 
R- CTGGTAGGCGATGTCCTTA 
476 F Tm = 55.5 
R Tm = 55.9 
Osteonectin 
(ON) 
F- ATGAGGGCCTGGATCTTCTT 
R- GCTTCTGCTTCTGAGTCAGA 
580 F Tm = 58.1 
R Tm = 57.3 
Smooth muscle 
α actin 
(SMAA) 
F- GTGTTGCCCCTGAAGAGCAT 
R- GCTGGGACATTGAAAGTCTCA 
109 F Tm = 60.6 
R Tm = 58.2 
Calponin 1 
(CNN1) 
F- CAACCACCACGCACACAACTA 
R- GGTCCAGCCAAGAGCAGCAG 
97 F Tm = 61.3 
R Tm = 63.4 
β-Myosin 
Heavy Chain  
(β-MHC) 
F- GATCACCAACAACCCCTACG  
R- ATGCAGAGCTGCTCAAAGC  
528 F Tm = 58.3 
R Tm = 58.8 
Desmin  F- CCAACAAGAACAACGACG  
R- TGGTATGGACCTCAGAACC  
408 F Tm = 54.4 
R Tm = 55.7 
 
 
2.3.6. Von Kossa staining 
 Mineralization in the osteogenic samples was assessed with Von Kossa staining.  
The samples were incubated under a UV light in 5% silver nitrate (MP Biomedicals) for 
30 min.  The samples were then rinsed 3 times with ddH20, followed by incubation 
with 5% sodium thiosulfate (Sigma Aldrich) for 2 min [102].  ImageJ was used to 
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quantify the percentage of staining in 30 images per experiment.  All experiments were 
repeated.    
2.3.7. Statistical analysis 
Statistical significance was evaluated with a paired Student's t-test for 
comparison of t-dependent groups.  T-tests were used to analyze data between all 
passages for the AFM indentation, stress fiber diameter measurements, and Von Kossa 
staining.  Subsequent passages for undifferentiated and differentiated cells were 
analyzed for the qPCR data.  All values are reported as means ±SE unless otherwise 
stated. 
 
2.4. Results and Discussion 
2.4.1. Cell proliferation 
hMSCs were received at P2.  Each passage corresponded to approximately 2 
population doublings.  Experiments on undifferentiated cells (AFM indentation, stress 
fiber analysis) began at P3.  Differentiations began at P4 and were carried out at each 
passage until P9, when differentiations were considered unsuccessful.  Undifferentiated 
cells were analyzed until P11, at which point senescence occurred.  During extended 
culture, cells showed signs of aging, including slowed proliferation, increased cell 
debris, and a change in appearance, from spindle-shaped to a broad, flattened 
morphology (Figure 20), as previously described [87,88,103]. 
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Figure 20: Phase contract images of hMSCs at a) P4 and b) P9.  Cells at P4 are 
small and spindle-shaped, compared to larger, flattened cells at P9. 
 
2.4.2. AFM indentation 
Prior to differentiation, the average elastic modulus of hMSCs on TCPS was 
analyzed (Figure 21).  The elastic modulus of undifferentiated hMSCs remained fairly 
constant from P3 to P5 (approximately 6 kPa).  Significant increases (P<0.05) were 
observed from P6 (7.95±0.83 kPa) to P7 (10.93±1.04 kPa), and from P7 to P8 
(14.89±1.20 kPa).  After P8, the average elastic modulus value was 16 kPa.  The initial 
average elastic modulus of a stem cell population is likely dependent on donor age 
[104,105].  These results are generally consistent with other studies [71-73,86,106,107], 
with any differences attributed to donor, AFM tip geometry [78,108], and location of 
indentation, as elastic modulus values vary widely in a single cell [107]. 
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Figure 21: Change in elastic modulus from P3 to P11. (*P<0.05, **P<0.01) 
 
2.4.3. Actin stress fiber measurements 
The actin stress fiber diameters of undifferentiated cells on TCPS can be seen in 
Figure 22.  Slight increases occurred at every passage, with very significant (P<0.01) 
increases between each passage from P5 to P9.  It has previously been reported that 
hMSC elastic modulus is primarily dependent on actin fibers [72,109,110].  Titushkin et 
al. found that the elastic modulus decreased more than 75% when actin fibers were 
disrupted, but saw no statistically significant difference when microtubules were 
disrupted [72].  Similar findings have been reported for skeletal myocytes [109] and 
osteoblasts [110].  Therefore, it is evident that the increases in stress fiber diameter led 
to the changes in cell elastic modulus. 
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Figure 22: Change in actin stress fiber diameters from P3 to P11 (**P<0.01) 
 
 
2.4.4. Myogenic differentiations 
Myogenic differentiations were carried out at every passage from P4 to P9.  The 
protein expression of two myogenic markers, tropomyosin and sarcomeric actin, were 
assessed with immunocytochemistry (Figure 23).  Tropomyosin is a protein that 
regulates muscle cell contraction.  Tropomyosin interacts with actin and the troponin 
complex to control the attachment of crossbridges to actin [111].  The appearance of 
sarcomeric actin coincides with the appearance of contraction in cardiac and skeletal 
muscle cells [112,113].  Protein levels of tropomyosin and sarcomeric actin peaked at 
P7, but were barely visible prior to P6 and after P8.  At the passage of peak expression, 
P7, the average elastic modulus value of the undifferentiated cell population was 
10.93±1.04 kPa. It appears that this value may be most conducive to myogenic 
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differentiation of hMSCs.  The elastic modulus of fully differentiated hMSCs at passage 
7 was 14.71±0.98 kPa.  Engler et al. previously reported that the elasticity of skeletal 
muscle is approximately 12kPa [47].  Similar values have been reported for human 
skeletal muscle [114], murine myoblasts [109], and murine skeletal myocytes [115].  
Therefore, it appears that hMSCs most easily differentiate down the myogenic lineage 
when their elastic modulus is most similar to that of native muscle.  This novel finding 
may guide those using adult stem cells for muscle regeneration.   
 
Figure 23: Expression of myogenic markers in differentiated hMSCs from P4 to 
P9.  Tropomyosin can be seen in green, sarcomeric actin in red, and nuclei in blue. 
 
 
            mRNA expression in differentiated hMSCs on TCPS was investigated using 
qPCR (Figure 24Figure 28).   The myogenic markers desmin, SMAA, CNN1, β-MHC, 
and troponin T were examined.  Desmin is a muscle-specific intermediate filament that 
appears in the early formation of cardiac, skeletal, and smooth muscle.  Desmin is 
thought to be involved in myofibrillogenesis and provides mechanical support for 
muscle cells [116].  SMAA, the primary actin isotype found in vascular smooth muscle 
cells, is also transiently expressed in the development of cardiac and skeletal muscle 
[117].  CNN1  is a protein that interacts with F-actin and tropomyosin to control the 
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contraction of smooth muscle cells [118].  The mRNA expression of β-MHC was also 
investigated.  Myosin is the main component of thick filaments in sarcomeres.  Type II 
myosin, found in muscle cells, has two heavy chains and four light chains.  The heavy 
chains are each comprised of a globular head domain and a coiled tail domain [119].  In 
this study, a cardiac muscle-specific MHC isoform was used.  Troponin T is a 
component of the troponin complex (along with troponin C and I) that binds to 
tropomyosin to form the tropomyosin-troponin complex [111].  The troponin T isoform 
used in this study is cardiac-muscle specific.  It is interesting to note that the cells 
express markers associated with all types of muscle.  However, CNN1, a marker 
associated with smooth muscle, was much more upregulated than the cardiac muscle-
specific marker β-MHC.   
In general, endogenous levels of myogenic markers increased until P7, then 
decreased.  This trend has been reported before, as Siegel et al. reported peak intrinsic 
expression of myogenic markers troponin I and myosin light chain in hMSCs at P7 
[120].  In this study, a similar trend was observed in the differentiated cells, with peak 
expression at P7.  It seems evident that the increased upregulation of myogenic markers 
in undifferentiated cells from P4 to P7, as well as the stiffening of cells to an optimal 
elasticity (approx. 11kPa), both contribute to the success of the myogenic differentiation 
at P7.   
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Figure 24: Fold change (ΔCt) of desmin compared to housekeeping gene (GAPDH) 
for hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between subsequent 
passages of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between differentiated 
samples) 
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Figure 25: Fold change (ΔCt) of SMAA compared to housekeeping gene (GAPDH) 
for hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between subsequent 
passages of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between differentiated 
samples) 
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Figure 26: Fold change (ΔCt) of CNN1 compared to housekeeping gene (GAPDH) 
for hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between subsequent 
passages of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between differentiated 
samples) 
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Figure 27: Fold change (ΔCt) of β-MHC compared to housekeeping gene 
(GAPDH) for hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between 
subsequent passages of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between 
differentiated samples) 
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Figure 28: Fold change (ΔCt) of Troponin T compared to housekeeping gene 
(GAPDH) for hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between 
subsequent passages of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between 
differentiated samples) 
 
2.4.5. Osteogenic differentiations 
            Osteogenic differentiations were carried out at every passage from P4 to P9.  
ON, OP, and OC expression were assessed with immunocytochemistry (Figure 29).  
ON is an extracellular matrix glycoprotein that initiates mineralization through binding 
to collagen and hydroxyapatite [121].  ON protein expression appears to decrease after 
P4, with no expression at P9.  OP is a protein that regulates mineralization by binding to 
hydroxyapatite, while OC is involved in regulation of mineral deposition and is a 
marker of mature osteoblasts [122].  OP expression was minimal from P7 to P9, while 
OC expression was minimal at P8 and P9.  Since both OP and OC are expressed in the 
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later stages of differentiation, the lack of expression after P7 indicates unsuccessful 
differentiations.   
 
 
Figure 29: Expression of osteogenic markers in differentiated hMSCs from P4 to 
P9.  ON, OP, and OC can be seen in red and nuclei in blue. 
 
    
qPCR results for osteogenic hMSCs on TCPS can be seen in Figure 30-Figure 
34.  The osteogenic markers ALP, Col 1, Runx2, OC, and ON were examined.   ALP is 
a metalloenzyme that initiates mineralization and peaks at day 14 of differentiation 
[123].  ALP generally decreased after extended culture in differentiated cells, with a 
significant (p<0.1) decrease from P8 to P9, with downregulation at P9 compared to 
undifferentiated cells.  This may indicate the cells’ inability to produce a mineralized 
matrix in P8-P9.  Col 1 is the main collagen protein in the bone matrix, and its gene 
expression typically peaks in the first 2 weeks of differentiation [124].  Significant 
(P<0.05) decreases in Col 1 expression in differentiated cells were observed between P7 
and P9, accompanied by downregulation after P7.  Runx2 is an essential transcription 
factor in osteogenesis that regulates OC and OP expression [125].  Interestingly, 
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significant (p<0.01) increases were seen in undifferentiated cells from P7 to P9, 
although differentiations at these passages were generally considered unsuccessful 
because of the lack of osteogenic protein expression.  Significant (P<0.05) decreases 
were detected in OC expression in differentiated cells from P7 to P9, with 
downregulation after P7 compared to undifferentiated cells.  Additionally, very 
significant (P<0.01) decreases in ON expression was observed from P5 to P6 in 
undifferentiated cells, and from P6 to P7 in differentiated cells.  A large increase in cell 
elastic modulus was observed from P7 (10.93±1.04 kPa) to P8 (14.89±1.20 kPa), which 
are the passages where several key players in osteogenesis are downregulated.  hMSCs 
undergoing osteogenesis have been shown to soften by approximately 33% early in 
differentiation, which was attributed to the actin network reorganization during 
differentiation [72].  This suggests that hMSCs may have more differentiation success 
in earlier passages, when they exhibit reduced endogenous cell stiffness.     
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Figure 30: Fold change (ΔCt) of ALP compared to housekeeping gene (GAPDH) 
for hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between subsequent 
passages of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between differentiated 
samples) 
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Figure 31: Fold change (ΔCt) of Col 1 compared to housekeeping gene (GAPDH) 
for hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between subsequent 
passages of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between differentiated 
samples) 
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Figure 32: Fold change (ΔCt) of Runx2 compared to housekeeping gene (GAPDH) 
for hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between subsequent 
passages of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between differentiated 
samples) 
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Figure 33: Fold change (ΔCt) of OC compared to housekeeping gene (GAPDH) for 
hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between subsequent passages 
of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between differentiated samples) 
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Figure 34: Fold change (ΔCt) of ON compared to housekeeping gene (GAPDH) for 
hMSCs from P4 to P9 (*P<0.1, **P<0.05, ***P<0.01 between subsequent passages 
of control samples, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 between differentiated samples) 
 
2.4.6. Von Kossa staining 
A mineralized matrix is a hallmark of successful osteogenesis.  The 
mineralization in osteogenic samples was quantified using Von Kossa staining.  
Calcium deposits appear in black after treatment with silver nitrate.  The amount of 
calcium deposits is decreased in higher passages compared to lower passages (Figure 
35).  The percentage of matrix mineralization was quantified with ImageJ (Figure 36).  
Significant decreases between subsequent passages were observed from P5 to P6 and 
from P7 to P8.  The large decline in mineralization from P5 to P6 (approximately 66%) 
signifies that the differentiations had the highest success in P4 and P5.  These results 
agree with the immunocytochemistry and qPCR data, which depict the decreases in ON 
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and ALP, both which are crucial for mineralization.  ON protein expression appears to 
decrease after P4, with no expression at P9, while ON mRNA expression decreased 
from P6 to P7.  Additionally, ALP mRNA expression generally declined during 
extended passaging, with a significant (P<0.1) decrease from P8 to P9. 
 
 
 
Figure 35: Von Kossa staining in a) P5 and b) P8 osteoblasts shows a decrease in 
higher passages 
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Figure 36: Von Kossa staining in osteogenic samples from P4 to P9. (**P<0.01) 
   
 We report that the average local elastic modulus of the hMSC population 
increases as cells age in vitro, and that this change in elastic modulus dictates 
differentiation success.  Osteogenic differentiations were more successful in the earlier 
passages (P4 to P6), when cells exhibited a lower elastic modulus value.  While it has 
previously been reported that hMSCs lose their osteogenic potential after long term in 
vitro culture, most studies have confirmed osteogenic decline by mineralization assays 
[10,87,88,90,93,94].  Few studies have examined osteogenic markers during in vitro 
aging [126,127], which revealed some of the trends that led to decreased differentiation 
capacity.  While osteogenic differentiations were most successful from P4 to P6, 
myogenic differentiation success peaked at P7, due to an elastic modulus value 
matching native muscle.  The myogenic potential of aging hMSCs had not been 
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explored until the present study.  While much of the focus on aging hMSCs has been on 
the osteogenic, chondrogenic, and adipogenic lineages [87,88,93,128,129], the 
myogenic lineage is one that may be very useful for regenerative medicine.  Further 
investigation must be done to elucidate the mechanisms behind cell stiffening during 
aging, as well as how it relates to chondrogenic and adipogenic differentiation in 
extended culture. 
 It is known that stem cell fate can be modulated by cell shape and cytoskeletal 
tension [55,57].  Additionally, the mechanical properties of adipose-derived stem cells 
have been shown to reflect their differentiation potential [130].  Here we show how 
stem cell fate is reliant on the average elastic modulus of an aging population.  While 
this study verifies stiffness-related changes during aging, it calls attention to the need 
for a stem cell culture substrate that does not induce rapid cell stiffening.  It also 
demonstrates the need for analysis of lineage-specific markers prior to differentiation.    
A mechanism that may play a role in the decrease of osteogenic potential and 
peak of myogenic potential is the GTPase RhoA.  Studies have shown that RhoA 
activity, along with Rho-associated protein kinase Rock, can induce osteogenesis in 
hMSCs [55,131].  On the contrary, Beqaj et. al showed that RhoA levels were 
downregulated in smooth muscle myogenesis and that upregulation of RhoA delays 
myogenesis in embryonic MSCs [132].  Likewise, Kim et al. reported downregulated 
RhoA and upregulated Rac1 during cardiomyogenic differentiation of hMSCs [133].  
RhoA was also downregulated during the skeletal muscle differentiation of avian 
myoblasts and mouse satellite cells [134].  Therefore, the endogenous levels of active 
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RhoA may be higher in earlier passages (P3-P6), and decrease at P7, which would lead 
to the peak myogenic differentiation at this passage. 
2.5. Conclusions 
Cells passaged on TCPS were subject to cell stiffening.  The average elastic 
modulus of undifferentiated cells remained constant (approximately 6 kPa) from P3 to 
P5.  Significant increases (P<0.05) were observed from P6 (7.95±0.83 kPa) to P7 
(10.93±1.04 kPa) and P8 (14.89±1.20 kPa).  After P8, the average elastic modulus value 
was 16 kPa.  These increases in cell elastic modulus were likely a result of increases in 
actin stress fiber diameters.  Elastic modulus values of hMSCs largely dictated the 
success of myogenic differentiation.  Highest expression of myogenic markers was 
observed at P7, where the elastic modulus was 10.93±1.04 kPa, which is comparable to 
previously reported values for muscle cells.  Osteogenic differentiations were more 
successful in earlier passages (P4 through P6), which may suggest that hMSCs more 
easily differentiate when in a softer state.  This is the first report that correlates the 
average elastic modulus of an aging cell population to its differentiation success, as well 
as the first study of myogenic potential during in vitro aging.  This study illustrates the 
importance of mRNA and protein analysis during extended culture, while 
demonstrating a need for a more suitable substrate for the extended culture of hMSCs.   
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Chapter 3: Mechanical Loading on Polymeric Foams: Effect on hMSC 
Differentiation 
 
 
3.1.Chapter Overview 
This chapter describes the use of mechanical loading for the differentiation of 
hMSCs.  Chemical cues are commonly used for differentiation, but mechanical cues 
may more accurately mimic in vivo conditions.  Tensile (5-20%) and compressive (2.5-
10%) loading were used to induce myogenic and osteogenic differentiation, 
respectively, on 3-D porous polymer scaffolds.  Results show that 10% tensile stretch 
upregulates myogenic markers.  All compressive loading conditions upregulated 
osteogenic markers, while the cells loaded at 2.5% expressed the highest amount of 
late-stage differentiation marker.  This study demonstrates that loading alone can 
accelerate differentiation on 3-D scaffolds. 
 
3.2. Introduction 
hMSCs are adult stem cells that can differentiate into various lineages, including 
bone, cartilage, fat, tendon, muscle, and potentially neurons [6-18].  Because of their 
multipotency, hMSCs have great potential for regenerative medicine and tissue 
engineering.  Differentiation is usually induced by chemical induction (i.e. growth 
factors, glucocorticoids).  However, mechanical loading may be a better approach to 
replicate in vivo conditions, and therefore, would control the differentiation more 
effectively than chemical induction and may be more clinically relevant.   
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It is known that mechanical cues are crucial to development and morphogenesis 
[135-137].  Further, in most mechanosensitive tissues, lack of mechanical loading can 
lead to tissue degradation or impaired function.  For example, strain is crucial for the 
contractile phenotype of vascular smooth muscle cells [138].  Additionally, lack of 
loading or microgravity can lead to severe bone loss [139].  Many attempts have been 
made to reproduce in vivo body conditions in in vitro cell culture using mechanical 
stimulation.  MSCs have been stimulated by cyclic stretch [140,141], compressive 
forces [142-145], 4-point bending [146], shear flow [147,148], perfusion [149,150], and 
cyclic hydrostatic pressure [151].  Mechanical loading can promote or inhibit cell 
proliferation [152], alignment [141,152-155] and differentiation [141-145,150,152-
154,156-167].  Depending on the amount of strain, frequency, and loading time, tensile 
loading can promote myogenesis [141,152-154,168], osteogenesis [140,163-
166,169,170], or tenogenesis [171] and compressive loading can promote osteogenesis 
[145,150,160] or chondrogenesis [142-144,156-159,161,172-180] of MSCs. 
While studies have examined the differentiation of hMSCs by compressive or 
tensile loading, many different loading conditions, times, and substrates have been used.  
Most studies have used a 2-D substrate, such as polydimethylsiloxane (PDMS), but a 3-
D substrate more accurately represents in vivo conditions.  The mechanical properties of 
the chosen material must be considered, as stiffness alone can induce differentiation of 
hMSCs [48].  Additionally, scaffolds must be able to withstand loading.  In this study, 
porous scaffolds were made out of polyurethane resin (PUR) and poly-DL-lactic acid 
(PLA)/polycaprolactone (PCL) blend with compressive moduli of 30 kPa and 140 kPa, 
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respectively [181].  PURs have been used in many biomedical applications, including 
pacemaker lead insulation and catheters [182].  Because of their elastomeric properties, 
PURs are commonly used for soft tissue engineering applications, such as skeletal 
muscle [183] and heart valves [184].   PCL and PLA are commonly used as a blend or a 
copolymer.  PLA/PCL blends and copolymers have been used for tissue-engineered 
bone [185-187], among other applications.  The purpose of this study was to assess the 
capability of hMSCs to differentiate solely with tensile or compressive cyclic loading in 
3-D porous foams.  hMSCs were grown on 3-D porous PUR or PLA/PCL scaffolds and 
subjected to continuous tensile (5-20%) or compressive loading (2.5-10%), respectively, 
for 3 days.  The mRNA levels of various osteogenic and myogenic markers were 
investigated to assess differentiation.  Comparable upregulation of myogenic markers 
was observed with 10% stretch and static culture on PUR.  All levels of compressive 
loading appeared to enhance osteogenesis, with 2.5% compression producing the most 
mature cells.    
 
3.3.Experimental Details 
3.3.1. Preparation of scaffolds 
 PUR (Texin 950) was purchased from Bayer MaterialScience (Pittsburgh, PA).  
PDLLA 3051D was purchased from Natureworks (Minnetonka, MN).  PCL was 
purchased from Sigma Aldrich.  PLA/PCL (50:50) blend was synthesized using 
microwave radiation [188].  The porous samples were prepared by a solvent casting/salt 
leaching method [189].  Polymers were dissolved in solvent to yield a solution of 5% 
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(w/v).  The solvents used for the PLA/PCL blend and Texin 950 were chloroform 
(VWR, West Chester, PA) and THF (Acros Organics, Morris Plains, NJ), respectively.  
NaCl particles (>125μm) (90% w/v) (Chemicals Inc., Gibbstown, NJ) were added to 
each solution.  The solution was cast into individual molds.  The scaffolds were air-
dried for 48 h to allow the solvent to evaporate.  They were subsequently removed from 
the mold and immersed in distilled deionized water at 60˚C for 48 h to leach out the 
salt.  Sample dimensions of PUR scaffolds were 100x20x1 mm.  The PLA/PCL blend 
scaffolds had a diameter of 15mm and thickness of 1 mm. 
 
3.3.2. Remote actuated bioreactors 
For continuous stimulation, a remote actuation mechanism was made.  The 
remote actuator consisted of a motor (Part # WGB234607, Global Industrial Charlotte, 
NC), a cam, and a swinging frame.  The swinging frame has an angular reciprocation 
inside a fixed frame.  This mechanism activates one or more coaxial cables. The cables 
can be connected in to mechanism at 4 different places, which results in 4 different 
displacements (Figure 37).   
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Figure 37: Remote actuator 
 
 
The tensile and compressive loading devices are shown in  Figure 38 and 
Figure 39, respectively. The tensile loading device contained clamps to hold the PUR 
scaffold in place, and put tensile cyclic force on one side of the scaffold.  In the 
compressive loading device, the PLA/PCL blend scaffold was held in place while the 
bottom stage moved up and down to compress the scaffold.  These devices are placed 
inside the incubator and run by cables.  
 
 
 
 Figure 38: Remote actuated tensile loading device  
 
 
69 
 
 
 
Figure 39: Remote actuated compressive loading device 
 
3.3.3. Cell culture 
hMSCs (PT-2501, Lonza, Walkersville, MD) were cultivated on TCPS dishes in 
Mesenchymal Stem Cell Basal Medium supplemented with MSCGM SingleQuots 
(Lonza).  Scaffolds were UV sterilized for 48 h and then incubated in media for 24 h 
prior to seeding.  Approximately 5x10
5
 and 2x10
5
 cells (passages 5-7) were seeded onto 
the PUR and PLA/PCL blend scaffolds, respectively.  Cells were allowed to adhere for 
24 h prior to the start of loading.  The scaffolds were then subjected to compressive or 
tensile loading on PLA/PCL blend or PUR scaffolds, respectively, for 3 days.  hMSCs 
grown for 3 days on PLA/PCL blend or PUR scaffolds without loading  were used as 
negative control samples.  Positive control samples for compressive and tensile loading 
were grown in osteogenic or myogenic media, respectively, in TCPS dishes for 3 days 
(period of loading) or 28 days (full differentiation).  Osteoinductive media contained 
DMEM Low Glucose with L-glutamine, glucose, and sodium pyruvate (HyClone 
Laboratories, Logan, UT) supplemented with 10% fetal bovine serum (FBS) (HyClone 
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Laboratories), 0.1μM dexamethasone (EMD Millipore, Billerica, MA), 10 mM β 
glycerol phosphate (Sigma Aldrich), and 0.05 mM ascorbic acid (Acros Organics, 
Morris Plains, NJ).  To induce myogenic differentiation, 5 mM azacytidine (MP 
Biomedicals) was added to media (DMEM Low Glucose, 10% FBS) once a week for 24 
hours, for 4 weeks.   
3.3.4. qPCR 
Total RNA was isolated after 3 days of loading using RNeasy Plus Micro kits 
(Qiagen, Valencia, CA).  RNA was converted to cDNA using a Qiagen Omniscript RT 
Kit.  Cycles were optimized for the amplicon size and primer Tm on a Qiagen Rotor-
Gene qPCR system.  A SYBR green qPCR kit from Qiagen was used to assess gene 
expression.  Primers used for tensile and compressive loading are shown in Table 2 and 
Table 3, respectively.  Fold changes were determined through ΔΔCt comparison to the 
negative control (undifferentiated hMSCs).  Primer efficiency values were empirically 
derived from undifferentiated hMSCs for the housekeeping gene (GAPDH) and from 
osteogenic and myogenic hMSCs for differentiation markers.  The copy rate for each 
primer was found using the slope of the efficiency curve.  Fold changes were 
determined through ΔΔCt comparison, and all data was subject to normalization to the 
housekeeping gene (GAPDH) corresponding to each experimental condition and 
specimen. The ΔΔCt was calculated using the Ct of both the housekeeping gene (HKG) 
and the gene of interest (GOI) for the experimental and control conditions: 
                                        
 
        
         
 
            
             
                                          (34) 
71 
 
Statistical significance was evaluated with a paired Student's t-test for comparison of t-
dependent groups.   
 
 
Table 2: qPCR primers for tensile loading 
 
Target/control  
gene 
Primer Sequence (5’-3’) Amplicon  
Size 
Tm 
GAPDH F- CGGATTTGGTCGTATTGG  
R- TCAAAGGTGGAGGAGTGG 
861 F Tm = 53 
R Tm = 56 
β-Myosin Heavy  
Chain (β-MHC) 
F- GATCACCAACAACCCCTACG  
R- ATGCAGAGCTGCTCAAAGC  
528 F Tm = 58 
R Tm = 59 
Smooth muscle  
Α-actin (SMAA) 
F- GTGTTGCCCCTGAAGAGCAT 
R- GCTGGGACATTGAAAGTCTCA 
109 F Tm = 61 
R Tm = 58 
Calponin 1 
(CNN1) 
F- CAACCACCACGCACACAACTA 
R- GGTCCAGCCAAGAGCAGCAG 
97 F Tm = 61 
R Tm = 63 
Collagen 1  
(Col 1) 
F- ATCCAGCTGACCTTCCTGCG 
R- TCGAAGCCGAATTCCTGGTCT 
323 F Tm = 62 
R Tm = 61 
  
 
Table 3: qPCR primers for compressive loading 
 
Target/control  
gene 
Primer Sequence (5’-3’) Amplicon  
Size 
Tm 
GAPDH  F- CGGATTTGGTCGTATTGG  
R- TCAAAGGTGGAGGAGTGG 
861 F Tm = 53 
R Tm = 56 
Runx2   F- CCACCCGGCCGAACTGGTCC  
R- CCTCGTCCGCTCCGGCCCACA 
258 F Tm = 68 
R Tm = 71 
Osteocalcin  
(OC) 
F- GAAGCCCAGCGGTGCA 
R- CACTACCTCGCTGCCCTCC 
70 F Tm = 60 
R Tm = 62 
Col 1 F- ATCCAGCTGACCTTCCTGCG 
R- TCGAAGCCGAATTCCTGGTCT 
323 F Tm = 62 
R Tm = 61 
Collagen II  
(Col II) 
F- GAAACCATCAATGGTGGCTTCC 
R- CGATAACAGTCTTGCCCCACTT 
301 F Tm = 60 
R Tm = 62 
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3.4. Results and Discussion  
3.4.1. Tensile Loading qPCR Results 
 hMSCs on porous PUR scaffolds were stretched at 5%, 10%, 15%, and 20% for 
3 days and mRNA expression was examined.  hMSCs stretched at 20% underwent 
extensive cell death, and therefore, the mRNA could not be analyzed.  hMSCs on PUR 
were compared to cells in myogenic media for 3 days (MM 3d) and 28 days (MM 28).  
Both smooth and cardiac muscle markers were used, as tensile loading has been shown 
to induce both types of muscle [141,152-155,162,190]. The mRNA expression of β-
MHC, a cardiac specific isoform, was investigated (Figure 40).  Myosin is the main 
component of thick filaments in sarcomeres.  Type II myosin, found in muscle cells, has 
two heavy chains and four light chains.  The heavy chains are each comprised of a 
globular head domain and a coiled tail domain [119].  β-MHC is downregulated 
compared to undifferentiated cells in all conditions, suggesting that hMSCs do not take 
on a cardiomyogenic phenotype, although the samples stretched at 10% displayed 
comparable levels to cells treated with 5-aza for 4 weeks.   
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Figure 40: Fold change (ΔΔCt) of β-MHC compared undifferentiated hMSCs 
(*P<0.1, **P<0.05, ***P<0.01 compared to MM 3d, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 
compared to MM 28d) 
 
 
The mRNA levels of SMAA and CNN1, two smooth muscle markers, were also 
examined.  SMAA is the primary actin isotype found in vascular smooth muscle cells, 
and is also transiently expressed in the development of cardiac and skeletal muscle 
[117].  Comparable levels of upregulation of SMAA were observed in 10%, 15%, and 
static culture on PUR, and all three conditions were significantly upregulated compared 
to MM 3d and MM 28d (Figure 41).  Because SMAA is considered an early marker for 
smooth muscle, it is especially significant that these conditions had upregulated mRNA 
expression compared to MM 3d, indicating that they may accelerate smooth muscle 
myogenesis.  CNN1  is a protein that interacts with F-actin and tropomyosin to control 
the contraction of smooth muscle cells, and is considered an intermediate marker [118].  
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hMSCs on PUR had the most significant upregulation (P<0.05) compared to MM 3d 
and MM 28d (Figure 42).  An upregulation was observed with 10% stretch, but was not 
considered significant (P<0.15 compared to MM 3d, MM 28d).  Downregulation of 
CNN1 was detected with 5% and 15% stretch.  The levels of CNN1 in MM 3d and MM 
28d were also downregulated, due to the fact that peak expression most likely occurs in 
the first 2 weeks.  While upregulation of SMAA mRNA was observed for 10%, 15%, 
and PUR, the upregulated mRNA levels of CNN1 in 10% and PUR may indicate that 
the cells are more mature, as CNN1 is an intermediate marker.   
 
 
 
Figure 41: Fold change (ΔΔCt) of SMAA compared undifferentiated hMSCs 
(*P<0.1, **P<0.05, ***P<0.01 compared to MM 3d, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 
compared to MM 28d) 
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Figure 42: Fold change (ΔΔCt) of CNN1 compared undifferentiated hMSCs 
(*P<0.1, **P<0.05, ***P<0.01 compared to MM 3d, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 
compared to MM 28d) 
 
 
Col 1 is present in vascular smooth muscle, where it is indicative of a synthetic 
(immature) phenotype, but can help to promote a contractile phenotype and 
proliferation [191].  It is also the main protein component of bone [124], and therefore, 
is frequently used as an osteoblast marker.  Significant (P<0.1) upregulation of Col 1 
was observed with 10% stretch and PUR, while 5% and 15% loading downregulated 
Col 1 (Figure 43).  While the upregulation of Col 1 could also be indicative of 
osteogenic differentiation, the same trends that are seen in Col 1 expression were 
observed with CNN1 expression.  Therefore, it is believed that cells exposed to 10% 
loading and PUR (no loading) are developing a myogenic phenotype.   
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Figure 43: Fold change (ΔΔCt) of Col 1 compared undifferentiated hMSCs 
(*P<0.1, **P<0.05, ***P<0.01 compared to MM 3d, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 
compared to MM 28d) 
 
 
 In vivo, aortic smooth muscle cells undergo 9-12% strain [192].  In vitro studies 
typically stretch at 10% to induce myogenesis, but most studies have been conducted on 
2-D PDMS substrates [141,152,155,193].  Park et al. stretched hMSCs on PDMS at 
10% and 1 Hz [141].  Smooth muscle markers (SMAA and SM-22α) were upregulated 
after 1 day of loading, but expression decreased as cells oriented themselves 
perpendicularly to the direction of strain, demonstrating the need for the cells to remain 
parallel to strain, as in native blood vessels.  In previous studies, MSCs stretched on 2-D 
substrates generally oriented perpendicularly to direction of applied strain 
[141,152,155], while MSCs stretched on 3-D substrates oriented parallel to strain [154].   
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Rat MSCs in a 3-D fibrin gel not only oriented parallel to strain (10%, 1 Hz for 6 days), 
smooth muscle markers SMAA and CNN1 were also upregulated [154].   However, 
there was a need for a 3-D study to be carried out with hMSCs.  
This study stretched hMSCs at 5%, 10%, 15%, and 20% at 1 Hz on 3-D PUR 
scaffolds for 3 days.  Both 10% stretch and PUR upregulated SMAA, CNN1, and Col 1.  
When t-tests were done to compare these upregulations, no statistical significance was 
found.  Therefore, the material alone may accelerate myogenic differentiation as well as 
10% cyclic stretch.  However, tensile loading has been shown to promote cell 
alignment.  In the native blood vessel, smooth muscle cells are oriented parallel to the 
direction of strain.  In previous studies, MSCs stretched on 2D substrates generally 
oriented perpendicularly to direction of applied strain [141,152,155], while MSCs 
stretched on 3D substrates oriented parallel to strain [154].  More studies must be done 
to investigate the effects of 10% loading in a 3-D porous PUR scaffold on cell 
alignment. 
 
3.4.2. Compressive Loading qPCR Results 
 hMSCs on porous PLA/PCL blend scaffolds were compressed at 2.5%, 5%, 
7.5%, and 10% for 3 days and mRNA expression was examined.  hMSCs on PLA/PCL 
were compared to cells in osteogenic media for 3 days (OM 3d) and 28 days (OM 28).  
Various osteogenic markers (Runx2, OC, Col 1) as well as an additional extracellular 
matrix (ECM) marker (Col II), were investigated.  Runx2 is an essential transcription 
factor in osteogenesis that regulates OC, among other genes [125].  It is expressed prior 
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to an osteoblast phenotype and may regulate the inhibition of proliferation, which is 
necessary for differentiation [194]. All loading conditions, as well as static culture on 
PLA/PCL, upregulated Runx2 compared to OM 3d (Figure 44).  This is significant as 
Runx2 is an early osteogenic marker.  Compressive loading at 7.5% had the highest 
upregulation (P<0.05), followed by static culture on PLA/PCL (P<0.05).   
 
 
 
Figure 44: Fold change (ΔΔCt) of Runx2 compared undifferentiated hMSCs 
(*P<0.1, **P<0.05, ***P<0.01 compared to OM 3d, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 
compared to OM 28d) 
 
 
 
Col 1 is the main collagen protein in the bone matrix, and its gene expression 
typically peaks in the first 2 weeks of differentiation, during the matrix maturation 
phase of osteogenesis [124].  Col 1 mRNA expression was upregulated with 7.5% 
(P<0.1) and 5% (not significant, P<0.15) loading, and was downregulated with 2.5% 
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loading and static culture on PLA/PCL scaffolds (Figure 45).  Corresponding to the 
results of Runx2 mRNA expression, it appears that 7.5% compressive loading 
accelerates an early stage of osteogenesis.     
 
 
 
Figure 45: Fold change (ΔΔCt) of Col 1 compared undifferentiated hMSCs 
(*P<0.1, **P<0.05, ***P<0.01 compared to OM 3d, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 
compared to OM 28d) 
 
 
A marker of mature osteoblasts, OC, was also investigated.  OC is involved in 
regulation of mineral deposition and peaks in the fourth week of osteogenesis [122].  
OC was significantly upregulated in all conditions compared to OM 3d (Figure 46).  
Loading at 2.5% significantly upregulated (P<0.1) OC compared to OM 28d.  This is 
noteworthy because OC peaks during the mineralization phase of osteogenesis, and is 
80 
 
necessary for successful differentiation.  Therefore, 2.5% compressive loading 
accelerated the upregulation of a late-stage osteogenic marker.   
 
 
 
Figure 46: Fold change (ΔΔCt) of OC compared undifferentiated hMSCs 
(*P<0.1, **P<0.05, ***P<0.01 compared to OM 3d, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 
compared to OM 28d) 
 
Col II expression was also investigated, as compressive loading can also induce 
chondrogenesis [142-144,156-159,161,172-180].  Col II is typically a marker of matrix 
formation in chondrogenesis [195].  While Col II mRNA expression was upregulated in 
some conditions (Figure 47), the levels were not significantly higher than OM 3d.  
Therefore, the loading conditions seem to have upregulated the mRNA expression of an 
ECM protein that is intrinsically expressed by hMSCs. 
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Figure 47: Fold change (ΔΔCt) of Col II compared undifferentiated hMSCs 
(*P<0.1, **P<0.05, ***P<0.01 compared to OM 3d, 
#
P<0.1, 
##
P<0.05, 
###
P<0.01 
compared to OM 28d) 
 
 
Due to the large variations in compressive loading conditions, it is difficult to 
compare results from various studies.  While typical strains on bone in vivo are 0.3-5% 
[196], in vitro studies frequently use larger strains of 10%.  Additionally, many different 
loading regimens (from minutes per day to continuous loading), experiment lengths 
(from hours to weeks), and frequencies (typically 0.5-1 Hz) have been used.  The 
following is a summary of relevant studies.   
In conjunction with osteogenic media (typically ascorbic acid, β-glycerol 
phosphate, and dexamethasone), compressive loading has been shown to upregulate 
osteogenic markers [145,150].  hMSCs on glass were loaded at 1 Hz twice a day (10 
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minutes each) for 7 days with a pressure of 5 kPa [145].  A significant increase in ALP 
and calcium deposition was seen in the stimulated group compared to the group with no 
stimulation.  hMSCs have also been grown on bovine spongiosa disks and subjected to 
perfusion and cyclic compression of 10% at 0.5 Hz for 21 days [150].  The cells 
subjected to both perfusion and compression had the highest amount of OC expression 
(compared to perfusion alone and static culture).  While the addition of loading to the 
osteogenic media enhances osteogenesis, it is necessary to determine if loading alone 
can have similar effects. 
To assess the effect of loading without dexamethasone, hMSCs on a PUR foam 
were loaded using a protocol deemed successful with mature osteoblasts (5% strain at 1 
Hz for 2 hours on day 9 and then every 5 days up to and including day 19) [160].  The 
combination of loading and dexamethasone generally had the highest expression of all 
osteogenic markers tested.  However, the amounts of collagen and calcium at day 24 
were comparable between the group of loading alone and loading and dexamethasone, 
suggesting that the cells could mature equally in both groups.  Another study loaded 
hMSCs on collagen-alginate scaffolds at 10% compression for 4 hours a day for 21 days 
and found upregulation of Runx2 compared to static controls, although no other 
osteogenic markers were assessed [197].  While Runx2 is an essential transcription 
factor in osteogenesis, its upregulation is not enough to confirm osteogenesis.   
The present study evaluates the mRNA expression of various osteogenic 
markers in the absence of differentiation media.  Four different loading conditions were 
used: 2.5%, 5%, 7.5%, and 10%, all at 1 Hz for 3 days.  While 5-10% strain has been 
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used in previous studies, a smaller amount of strain may more accurately match in vivo 
conditions.  All loading conditions, as well as static culture on PLA/PCL, upregulated 
an essential transcription factor in osteogenesis (Runx2) compared to OM 3d, with the 
highest levels observed in 7.5% loading and PLA/PCL.  Additionally, Col 1 mRNA was 
upregulated with 5% and 7.5% compressive loading, indicating that the matrix 
maturation phase had begun.  OC was significantly upregulated in all conditions 
compared to OM 3d, and 2.5% upregulated OC compared to OM 28d.  These results 
indicate that the cells subjected to all loading conditions may have accelerated 
osteogenesis.  However, cells compressed at 2.5% may be the most mature, as OC, a 
late-stage marker, was upregulated compared to OM 28d.  The mRNA levels of Runx2 
and Col 1 in cells loaded at 2.5% may have been already upregulated, and then 
consequently downregulated, as OC levels rose.  These observations seem to agree with  
in vivo loading conditions, as 2.5% compressive loading is within the physiological 
range [196].  
While it is evident that mechanical loading can regulate the differentiation of 
hMSCs, the mechanisms behind this regulation still remain elusive.  Several 
possibilities include integrins [198], stretch activated cation channels [199], and focal 
adhesion proteins, such as vinculin and talin [200].  It is hypothesized that during 
mechanical loading, protein deformation occurs, which signals biochemical signaling 
[201].  Stretch activated ion channels (SACs) are mechanotransducers present in the 
membrane that respond to tension and fluid flow.  They have been implicated in the 
chondrogenic differentiation response of hMSCs to tensile strain [202] and therefore, 
84 
 
are of great interest.  In compressive loading, the SACCs may also be activated due to 
the fluid flow of media induced by the loading.  More studies must be done to 
determine the role of SACs in loading-induced differentiation to osteoblasts and 
myocytes.   
 
 
3.5. Conclusions 
 Mechanical loading as a means of differentiation may be a suitable replacement 
for chemical induction in the near future.  hMSCs were cyclically stretched at 5%, 10%, 
15%, and 20% on PUR.  Cell death was observed with 20% stretch.  mRNA levels of 
MHC were downregulated in all conditions, indicating a cardiomyogenic phenotype 
was not acquired.  Highest levels of SMAA, CNN1, and Col 1 were observed with 10% 
stretch and static culture on PUR, indicating these conditions can accelerate smooth 
muscle myogenesis.  hMSCs were also compressed at 2.5%, 5%, 7.5%, and 10% on 
PLA/PCL blend scaffolds.  While all loading conditions seemed to enhance 
osteogenesis to an extent, cells compressed at 2.5% seemed to mature the fastest, with a 
significant increase in OC compared to OM 28d.  This study indicates that tensile and 
compressive loading alone can induce myogenesis and osteogenesis, respectively, in 
hMSCs on 3-D porous scaffolds. 
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Chapter 4: Cardiogenic Potential of hMSCs by Embryoid Body Formation 
 
 
4.1. Chapter Overview 
hMSCs are considered a potential cell source for cardiac tissue engineering, due 
to their transdifferentiation potential and homologous availability.  Current 
differentiation methods are varied, but many use 5-azacytidine (5-aza) for 
differentiation.  5-aza use may be clinically discouraged, due to the potential for 
harmful demethylation activity.  Another method for transdifferentiation of hMSCs into 
cardiomyocytes is embryoid body culture, commonly used with embryonic stem cells.  
This method has been explored for potential in hMSC cardiomyocyte differentiation.  
However, the RNA expression of embryoid body-derived hMSCs has not been 
examined.  In this study, hMSCs were grown using the hanging drop method to form 
embryoid bodies.  Cellular differentiation was quantified by assessing cell outgrowth 
and cardiac marker expression.  Cells were positive for various cardiac markers 
(sarcomeric actin, tropomyosin, troponin T, myosin heavy chain, α-actinin), including 
the adherens junction protein, N-cadherin.  The genes GATA4, α-cardiac actin, β-
myosin heavy chain, troponin T, and desmin were upregulated compared to 
undifferentiated cells.  The cells also contained organized myofibrils and some Z bands, 
which are generally not observed after 5-aza treatment.  Therefore, the embryoid body 
method may be viable clinical alternative for cardiac differentiation of hMSCs.  
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4.2. Introduction 
Damage to heart muscle, whether is it acute or chronic, can often lead to heart 
failure.  In the United States, almost 300,000 people die from heart failure every year 
[203].  Because cardiomyocytes cannot significantly proliferate, the heart primarily 
responds to injury through ventricular remodeling and scar tissue formation, which 
leads to a decline in contractile function [204-206].  Cardiac tissue engineering aims to 
repair, regenerate, or replace injured myocytes and improve cardiac function after 
myocardial infarction.  Because the heart has limited resident stem cells [207-210], 
another cell source, such as skeletal myoblasts, embryonic stem cells, or MSCs, may be 
chosen.     
Bone marrow MSCs are a potential cell source for repair after myocardial 
infarction.  They are adult stem cells that can differentiate into different lineages, 
including bone, cartilage, fat, tendon, muscle, and possibly neurons [6-19].  They have 
the ability to proliferate in culture while retaining their multilineage potential.  Several 
groups have used hMSCs to aid in the repair of infarcted myocardium [211-216], but it 
is debated whether hMSCs fully differentiate after implantation [18,217].  Additionally, 
the safety of undifferentiated MSCs has been questioned.  There have been several 
reports of calcification after transplantation of bone marrow MSCs into an infracted 
heart [218,219].  Therefore, some researchers have suggested that it may be beneficial 
to differentiate the hMSCs prior to implantation [220,221].  
The demethylation agent 5-aza is commonly used to induce differentiation in 
hMSCs [222,223].  However, it has been reported that the frequency of differentiation 
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using this method is very low [224] or even unsuccessful [225].  Additionally, the 
demethylation action of 5-aza may be nonspecific [226].  Other methods to differentiate 
hMSCs include co-culture with cardiomyocytes [120,227-229], electrical stimulation 
[230,231], medium enriched with insulin, dexamethasone, and ascorbic acid [120,220], 
transforming growth factor (TGF) β1 [221], and a combination of 5-aza and oxytocin 
[232].  A combination of retinoic acid, activin A, alpha thrombin, interleukin-6, and a 
variety of growth factors has also been used to induce cardiac transcription factors 
while maintaining the proliferative state prior to implantation [233].  Cardiomyocyte-
differentiated hMSCs generally display cardiac markers, but lack the ability to contract 
in vitro.  Therefore, a method that can produce functional cardiomyocytes, preferably 
without chemical induction, is needed. 
Embryoid body (EB) formation is commonly used in the differentiation of stem 
cells, specifically ESCs [1,2,234,235] and embryonal carcinoma cells [236].  EBs are 
three-dimensional aggregates that contain multiple cell types that display a similar gene 
pattern to the developing embryo [112,237,238].  EB formation may be superior to 2D 
culture because it provides an environment that mimics in vivo conditions [239]. While 
EB formation has not been used extensively for hMSCs, it has been used to enhance 
osteogenic [240-245] and adipogenic differentiation [240,243], to create neural stem 
cell-like cells [246], and to enhance the anti-inflammatory properties of hMSCs [247].  
Potapova et al. used hMSC EBs to produce cardiomyogenic cells that displayed the 
cardiac markers α-actinin, troponin T, atrial natiuretic peptide, cardiotin, and Cav 1.2 (a 
voltage gated calcium channel).  Immunocytochemistry was performed at 4-7 days post 
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plating, at which point approximately 50% of the cells were positive for the cardiac 
markers.      
This study was conducted to further investigate the characteristics of hMSC-
derived cardiomyocytes produced by EB formation. The differentiation was carried out 
to 18 days post plating to examine whether or not the additional time would allow all 
cells to display cardiac proteins.  Several key proteins involved in cardiomyocyte 
contraction (tropomyosin, sarcomeric actin, and myosin heavy chain), as well as an 
adherens junction protein (N-cadherin) were examined.  Additionally, quantitative 
polymerase chain reaction (qPCR) was used to evaluate mRNA expression in EB-
derived cardiomyocytes, which had not been previously investigated.    
 
4.3. Experimental Details 
4.3.1. Cell culture and differentiation 
hMSCs were cultivated on TCPS dishes in Mesenchymal Stem Cell Basal 
Medium supplemented with MSCGM SingleQuots (Lonza, Walkersville, MD).  Cells 
were committed to a cardiac lineage by cultivating hMSCs (passages 6-7) into EBs 
using the hanging drop method as reported by Potapova et al. [248].  Approximately 25 
drops (40 µl each) of cell suspension in media (DMEM High Glucose with L-
glutamine, glucose, and sodium pyruvate, HyClone Laboratories, Logan, UT) 
supplemented with 30% FBS were cultivated for 3 days on the lids of bacteriological 
grade petri dishes (Figure 48).  Each drop contained approximately 2.5x10
5
 cells [248].  
The EBs were transferred to tissue culture treated glass coverslips and grown for an 
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additional 18 days.  Cell counts were performed at days 0, 5, 10, and 18.  The cells were 
detached from the glass using trypsin (HyClone Laboratories) and counted using a 
hemocytometer.  Statistical significance was evaluated with a paired Student's t-test for 
comparison of t-dependent groups.  The experiment was completed a total of three 
times. 
 
Figure 48: Method of EB formation.  Cells are suspended in a 40 µl drop on day 0.  
Cells aggregate for 3 days and are plated onto tissue culture treated glass 
coverslips.
 
 
4.3.2. Immunocytochemistry 
Fixation and immunocytochemical processing for sarcomeric actin, troponin T, 
myosin heavy chain (MHC), actinin, and tropomyosin expression were conducted using 
standard protocols.  Mouse monoclonal anti-sarcomeric actin (1:250) was purchased 
from Invitrogen (Carlsbad, CA).  The monoclonal antibodies MNCD2 (anti-N-cadherin, 
1:100), CT3 (anti-cardiac troponin T, 1:100) and ALD-58 (anti-myosin heavy chain, 
1:100), developed by Masatoshi Takeichi and Hiroaki Matsunami, Jim Jung-Ching Lin, 
and Donald A. Fischman, respectively, were obtained from the Developmental Studies 
Hybridoma Bank developed under the auspices of the NICHD and maintained by The 
University of Iowa, Department of Biology, Iowa City, IA 52242.  Sheep polyclonal 
anti-tropomyosin (1:500), mouse monoclonal anti-actinin (1:200), and mouse 
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monoclonal anti-connexin 43 (1:200) were purchased from Millipore (Billerica, MA).  
Briefly, cells were fixed with 10% formalin (Sigma Aldrich) in 1 x PBS for 15 minutes. 
The samples were then treated with 100% methanol for 7 minutes.  Non-specific 
binding sites were blocked with 1% bovine serum albumin (BSA) for 30 minutes at 
room temperature.  Primary antibodies were incubated for 1 h at 37°C, followed by 
incubation with appropriate secondary antibodies (Alexa Fluor 488, Alexa Fluor 555, 
and Alexa Fluor 647, 1:1000, Invitrogen) for 1 h at room temperature.  The nuclei were 
then counterstained with Hoechst dye (0.002 mg/ml in 1xPBS) for 5 minutes.  
4.3.3. qPCR 
qPCR was performed to assess mRNA expression of cardiomyocyte markers 
(Table 4).  Total RNA was isolated using an RNeasy Plus Micro Kit (Qiagen, Valencia, 
CA).  RNA was converted to cDNA using a Qiagen Omniscript RT Kit.  Cycles were 
optimized for the amplicon size and primer Tm on a Qiagen Rotor-Gene qPCR system.  
A SYBR green qPCR kit from Qiagen was used to assess gene expression.  Fold 
changes were determined through ΔΔCt comparison to the negative control 
(undifferentiated hMSCs).  Primer efficiency values were empirically derived from 
undifferentiated hMSCs for the housekeeping gene (GAPDH) and from cardiomyogenic 
hMSCs for cardiomyocyte markers.  The copy rate for each primer was found using the 
slope of the efficiency curve.  Fold changes were determined through ΔΔCt comparison, 
and all data was subject to normalization to the housekeeping gene (GAPDH) 
corresponding to each experimental condition and specimen. The ΔΔCt was calculated 
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using the Ct of both the housekeeping gene (HKG) and the gene of interest (GOI) for 
the experimental and control conditions.  Statistical significance was evaluated with a 
paired Student's t-test for comparison of t-dependent groups.   
 
Table 4: qPCR primers for cardiomyogenic differentiation 
 
Target/control 
Gene 
Primer Sequence (5’-3’) Primer  
Tm 
Amplicon 
 Size 
GAPDH  F- CGGATTTGGTCGTATTGG  
R- TCAAAGGTGGAGGAGTGG  
F Tm = 53 
R Tm = 56 
861 
Nkx2.5 F- CCAGCCAAGGACCCTAGAG  
R- AGCTCCACCGCCTTCTG 
F Tm = 59 
R Tm = 59 
359 
MEF2C F- GACTTTCTGAAGGATGGGCAA  
R- AAGTGCTAAGCTTATCTCAGCA  
F Tm = 58 
R Tm = 59 
233 
GATA4  F- GATGCCTTTACACGCTGATG  
R- GATGTCCCCGTGAATTGGGT  
F Tm = 57 
R Tm = 59 
400 
α-Cardiac  
Actin  
F- GCCTTCCTCATTTAAAGCTC  
R- AACACCACTGCTCTAGCCACG  
F Tm = 54 
R Tm = 63 
418 
β-MHC  F- GATCACCAACAACCCCTACG  
R- ATGCAGAGCTGCTCAAAGC  
F Tm = 58 
R Tm = 59 
528 
Desmin  F- CCAACAAGAACAACGACG  
R- TGGTATGGACCTCAGAACC  
F Tm = 54 
R Tm = 56 
408 
Troponin T  F- AGGCGCTGATTGAGGCTCAC 
R- ATAGATGCTCTGCCACAGC 
F Tm = 63 
R Tm = 57 
407 
 
 
4.4. Results and Discussion 
4.4.1. Cell Proliferation 
 hMSCs are a heterogeneous population with two main cell types: spindle-shaped 
cells and large flattened cells (Figure 49a) [10,249,250].  The hanging drop procedure 
produces EBs that are approximately 1mm in diameter (Figure 49b).  The differentiated 
(c) 
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cells growing outward from the EBs were elongated and appeared to be a homogeneous 
population (Figure 49c).  The cells aligned as they spread from the EB.   
 
 
Figure 49: Phase-contrast images of a) undifferentiated hMSC cells, b) an EB with 
aligned cardiomyocyte-like cells, c) aligned outgrowth from EB 
 
 Cell counts were performed at days 0, 5, 10, and 18 to determine proliferation 
(Figure 50).  The cell count at day 0 is representative of the EB alone, while the counts 
at days 5, 10, and 18 are representative of both the EB and the outgrowth.  The average 
number of cells at day 0 was 2.43±0.19 x10
5
 cells, indicating that slight cell death 
occurred during cell aggregation, most likely due to hypoxia in the EB [251].  
Significant cell growth did not occur between days 0 and 5.  However, cell growth was 
significant (P<0.01) between days 5 and 10, and days 10 and 18.   
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Figure 50: Proliferation of EB-derived cells from day 0 to 18 (*P<0.01 compared to 
previous cell count) 
 
4.4.2. Immunocytochemistry 
hMSC-derived cardiomyocytes have previously been tested for cardiac markers, 
but with mixed results from various differentiation procedures [220,252].  The hanging 
drop differentiation procedure (250,000 cells/40µl) used in this study, as reported by 
Potapova et al., produces cardiomyogenic cells that displayed the cardiac markers α-
actinin, troponin T, atrial natiuretic peptide, cardiotin, and Cav 1.2 [248].  The current 
study examines the expression of additional cardiac markers (sarcomeric actin, 
tropomyosin, n-cadherin, Cx43, and β-myosin heavy chain) at 18 days post-plating. All 
of the cardiac markers examined will be outlined below.   
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Sarcomeric actin appeared as filaments in the differentiated cells (Figure 51, a-
b).  Sarcomeric actin is a key component of the contractile unit in cardiac muscle, the 
sarcomere, and appears at day 8 in developing embryo [112].  Some undifferentiated 
hMSCs were weakly positive for sarcomeric actin (Figure 51c), but staining was diffuse 
and no striations were observed.  Muscle-specific proteins have previously been 
reported in untreated hMSCs [253]. This presence may suggest an inherent capacity for 
cardiomyogenic differentiation, and therefore, myocardial repair [233].   
 
 
 
Figure 51: Sarcomeric actin in hMSC-derived cardiomyocytes (a-b) and 
non-induced hMSCs (c) 
 
Clear striations were detected with tropomyosin staining (Figure 52, a-b).  
Tropomyosin is a protein that regulates sarcomeric contraction.  Tropomyosin interacts 
with actin and the troponin complex to control the attachment of crossbridges to actin.  
Therefore, the presence of this protein indicates that the cells may have the ability to 
contract.  Faint tropomyosin expression was observed in undifferentiated cells (Figure 
52c).  However, staining in undifferentiated cells was diffuse, while in cardiomyogenic 
cells, clearly aligned fibrils were observed.  As previously stated with regard to 
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sarcomeric actin, the existence of tropomyosin prior to differentiation may indicate an 
intrinsic ability for transdifferentiation.  
 
 
Figure 52: Tropomyosin expression in hMSC-derived cardiomyocytes (a-b) and 
non-induced hMSCs (c) 
 
Troponin T was observed as punctate staining throughout the hMSC-derived 
cardiomyocytes (Figure 53, a-b), and was not observed in undifferentiated hMSCs 
(Figure 53c). Troponin T is a component of the troponin complex (along with troponin 
C and I) that binds to tropomyosin to form the tropomyosin-troponin complex.  When 
Ca
2+
 binds to troponin C, a conformational change occurs in troponin I.  Myosin-
binding sites on actin that were previously blocked by tropomyosin are exposed.  The 
presence of troponin T indicates the cells’ ability to regulate contraction [111,254].    
  
 
 
Figure 53: Troponin T expression in hMSC-derived cardiomyocytes (a-b) and non-
induced hMSCs (c) 
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Myosin heavy chain was present in hMSC-derived cardiomyocytes (Figure 54, 
a-b), and was not observed in undifferentiated cells (Figure 54).  Myosin is the main 
component of thick filaments in sarcomeres.  Type II myosin, found in cardiomyocytes, 
has two heavy chains and four light chains.  Each heavy chain is comprised of a 
globular head domain and a coiled tail domain [119].  Myosin is responsible for the 
power stroke that causes cell contraction [111].  The hMSC-derived cardiomyocytes 
have the structural proteins necessary for contraction: sarcomeric actin (“thin” 
filaments), myosin (“thick” filaments), as well as the regulatory proteins tropomyosin 
and troponin T.    
 
 
 
Figure 54: Myosin heavy chain expression in hMSC-derived cardiomyocytes (a-b) 
and non-induced hMSCs (c) 
 
α-actinin, which plays a key role in the structure of cardiomyocytes, was present 
in all EB-derived cells (Figure 55, a-b).  It was not observed in undifferentiated hMSCs 
(Figure 55c).  It is a Z-band protein that crosslinks the actin/nebulin filaments in the 
myofibrils and also binds to titin [255].  Some cells displayed organized sarcomeres.  Z-
bands were evident with α-actinin staining (Figure 56), suggesting that some cells 
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contained mature myofibrils [256].   Additionally, Z-bands provide provide the support 
needed during cell contraction [255]. 
 
 
 
Figure 55: α-actinin expression in hMSC-derived cardiomyocytes (a-b) and non-
induced hMSCs (c) 
 
 
 
 
Figure 56: α-actinin staining clearly shows Z-bands in some cells 
 
N-cadherin is a calcium-dependent glycoprotein that is present in adherens 
junctions in cardiac muscle [257].  The intercalated disks of cardiomyocytes contain 
adherens junctions and gap junctions, which mechanically and electrically link cells, 
respectively.  While N-cadherin in mature cardiomyocytes is localized to cell-cell 
junctions, it was found throughout the differentiated cells (Figure 57, a-b).  It was not 
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present in undifferentiated cells (Figure 57c).  A study of knockout of N-cadherin in 
mouse embryos led to improper formation of the heart tube.  However, cells isolated 
from the embryos were able to weakly aggregate and contract, demonstrating that 
electrical coupling is possible in the absence of N-cadherin [258].  Additionally, 
deletion of the N-cadherin gene in adult mice led to disassembly of intercalated discs, 
which led to impaired cardiac function [259].  Therefore, N-cadherin is a necessary 
component of cell-cell junctions in cardiomyocytes.  The expression of N-cadherin in 
differentiated cells is promising, as it is crucial for the mechanical coupling of 
cardiomyocytes.  
 
 
 
Figure 57: N-cadherin expression in hMSC-derived cardiomyocytes (a-b) and non-
induced hMSCs (c) 
 
Gap junctions of cardiomyocytes are responsible for cell-to-cell communication, 
intercellular propagation of electrical signals, and exchange of small signaling 
molecules.  Connexin 43 (Cx43) is the predominant connexin expressed in cardiac 
tissue and is involved in the electrical coupling of the ventricles [260].  Cx43 was 
expressed in the aligned outgrowth (Figure 58).  A membrane stain was used to 
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visualize the localization of the Cx43 protein to the cell-cell junctions.  This localization 
suggests that the cells are coupled electrically. 
 
Figure 58: Cx43 expression in hMSC-derived cardiomyocytes (a-b) and non-
induced hMSCs (c).  Localization of Cx43 to cell junctions are denoted by white 
arrows in (b). 
 
4.4.3. qPCR 
mRNA was isolated from the specimens at 18 days post-plating and qPCR was 
performed.  Fold changes of cardiac muscle markers in experimental and control 
samples (undifferentiated hMSCs, passage 4) were calculated compared to the 
housekeeping gene GAPDH (Figure 59).  Three critical transcription factors were 
examined: Nkx2.5, MEF2C, and GATA4.  In murine embryos lacking Nkx2.5, looping 
morphogenesis, which is critical to heart function, was not initiated [261].  Another 
critical transcription factor, MEF2C, is also involved in looping morphogenesis, as well 
as right ventricle formation and the expression of cardiac genes such as α-cardiac actin 
[262].  GATA4 is required for heart tube formation in vivo [263].  Nkx2.5, MEF2C, and 
GATA4 mRNA were all significantly upregulated compared to the control, indicating 
milestones for cardiopoiesis had been met.  In early mouse embryonic development, 
gene expression of GATA4 is followed by β-MHC on day 4 [112].  β-MHC mRNA was 
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also significantly (p<0.05) upregulated compared to the control.  Although the normal 
gene expression timeline for troponin T, desmin, and α-cardiac actin are not known, 
these genes were all upregulated compared to the control.  Troponin T protein first 
appears on day 8 in embryonic mice [112].  Desmin is a muscle-specific intermediate 
filament that appears at day 9 in the developing heart.  Desmin is thought to be involved 
in myofibrillogenesis and mechanical support for muscle cells [116].  It is not essential 
for cardiac differentiation, but may be necessary for normal cardiac function [264]. The 
expression of desmin is followed by cardiac actin in the developing embryo [265].  
These results indicate that hMSC-derived cardiomyocytes are expressing key 
transcription factors (Nkx2.5, MEF2C, GATA4) along with several other important 
genes.   
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Figure 59: mRNA expression of hMSC-derived cardiomyocytes assessed by qPCR 
(*p<0.1, **p<0.05, ***p<0.01 upregulated over control) 
 
While the hMSC-derived cardiomyocytes displayed numerous contractile 
proteins, spontaneous contractions were not observed.  However, Potapova et al. patch-
clamped and found that 5 of out 31 cells had an L-type calcium current.  Based on the 
current-voltage relationship, it was determined that these cells displayed a voltage 
dependence and amplitude similar to adult human ventricular myocytes [248].  
Therefore, it may be necessary to electrically stimulate the cells before implantation.  
Additionally, gap junction formation in cardiomyocytes produced by EB formation 
must be examined, and will be the subject of future work. 
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EB formation is a useful tool for producing cardiomyogenic hMSCs. However, 
one drawback of this differentiation method is the number of cells needed to create EBs.  
This method requires 250,000 cells per 40 µL drop.  The authors tried using a lower 
number of cells per drop (100,000), but aggregates did not form (data not shown).  
Nevertheless, multiwell hydrogel systems [266], micropatterned substrates [240], or 
spinner flasks and rotating wall vessel bioreactors [243] may be used to create EBs of 
lower cell numbers.  More work must be done to determine the optimal number of cells 
per EB. 
While 5-aza has been used extensively to induce differentiation, success rates 
vary. Atonitsis et al. treated hMSCs with 10µM 5-aza for 24 hours (repeated 1x/week 
for 4 weeks) and found that the cells contained myofilaments that were positive for β-
MHC, but no sarcomeres were observed.  Using RT-PCR, they also found that the cells 
expressed the cardiac genes α-cardiac actin, β-MHC, and troponin T (although they 
were also expressed in undifferentiated cells) [222].  Xu et al. treated hMSCs with 
10µM 5-aza and 10µg/L basic fibroblast growth factor.  After a 24 hour treatment 
period, the media was replaced with normal growth media and the experiment was 
carried out for 2 weeks.  Approximately 80% of the cells were positive for desmin, α-
cardiac actin, and β-MHC. Additionally, the genes desmin, α-cardiac actin, β-MHC, and 
troponin T were highly expressed.  The study reported that the differentiated cells 
contained myofilament-like structures, but no sarcomere formation were observed 
[223].  On the other hand, Martin-Rendon et al. treated hMSCs with 3, 5, or 10µM 5-
aza for various time periods and reported that less than 1% of cells became 
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cardiomyocyte-like cells, suggesting that treatment of 5-aza may not be an effective 
differentiation method [224].  Mohanty et al. induced differentiation with TGFβ1 and 
compared it to treatment with 5-aza. While both treatments produced cells that 
expressed cardiac myosin, troponin I, and GATA4, levels were higher in the cells 
treated with 5-aza [221].  Therefore, the EB method may be preferred because of the 
presence of sarcomeres, which is indicative of mature myofibrils [256], and for the 
efficacy of the method, as all cells in this study were positive for the cardiac protein 
markers.   
Another differentiation treatment that has been used is insulin, dexamethasone, 
and ascorbic acid [220].  Shim et al. used this differentiation media for multiple 
passages.  RT-PCR analysis revealed the gene expression of GATA4 and MEF2, but 
not Nkx2.5/Csx, another critical transcription factor in cardiac differentiation.  These 
cells stained positive for numerous cardiac muscle markers (desmin, tropomyosin, 
troponin I, α-cardiac actin, and α-actinin, among others) and were negative for skeletal 
muscle markers.  Some Z bands were detected after 4-5 passages in differentiation 
media.  The EB method may be superior since it produced cells with Z bands after only 
18 days and does not use chemical induction. However, more studies should be done, 
specifically focused on electrical stimulation of cells to initiate the formation of 
functional gap junctions and spontaneous contractility.  
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4.5. Conclusion 
The hanging drop method for EB formation is a valuable method for producing 
hMSC-derived cardiomyocytes, and may be superior to chemical induction methods.  
The EB-derived cells displayed numerous cardiac contractile protein markers and 
contained organized myofibrils.  Some Z bands were visualized with α-actinin staining, 
indicating mature myofibrils.  N-cadherin, an adherens junction protein necessary for 
mechanical coupling during cell contraction, was present, but was not localized to cell-
cell junctions.  However, Cx43, a gap junction protein, was localized to cell-cell 
junctions.  Several cardiac muscle genes, α-cardiac actin, troponin T, β-MHC, and 
desmin, along with key transcription factors, Nkx2.5, MEF2C, and GATA4, were 
upregulated compared to undifferentiated cells.  Given the success rate of this 
differentiation method, and absence of chemical induction, it may prove to be a viable 
clinical option for future cardiac cell therapies derived from hMSCs. 
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Chapter 5: In Vitro Comparative Biodegradation Analysis of Salt-Leached Porous 
Polymer Scaffolds 
 
5.1. Chapter Overview 
This study presents a comprehensive, side-by-side analysis of chemical, thermal, 
mechanical, and morphological changes in four polymers used in tissue engineering: 
poly(glycerol-sebacate) (PGS), poly(lactic acid) (PLA)/poly(ε-caprolactone) (PCL) 
blend, poly(lactic-co-glycolic acid) (PLGA), and Texin 950, a segmented polyurethane 
resin (PUR).  Polymer foams were created using a salt-leaching technique and then 
analyzed over a sixteen week period.  Biodegradation was analyzed by examining the 
morphology, thermal properties, molecular weight, chemical and mechanical properties 
using scanning electron microscopy, differential scanning calorimetry, gel permeation 
chromatography, attenuated total reflectance-Fourier transform infrared spectroscopy, 
thermogravimetric analysis, and compression testing.  PGS underwent the most rapid 
degradation, and was hallmarked by a decrease in compressive modulus.  PLA/PCL 
blend and PLGA both had rapid initial decreases in compressive modulus, coupled with 
large decreases in molecular weight.  Surface cracks were observed in the PUR 
samples, accompanied by a slight decrease in compressive modulus.  However, as 
expected, the molecular weight did not decrease.  These results confirm that PUR does 
not undergo significant degradation, but may not be suitable for long term implants.  
The biodegradation rates of porous PGS, PLA/PCL blend, and PLGA found in this 
study can guide their use in tissue engineering and other biomedical applications. 
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5.2. Introduction  
 A wide array of porous polymeric scaffolds has been examined for tissue 
engineering applications.  Natural materials include collagen (cardiac and cartilage 
tissue engineering) [267-270], gelatin [271,272], and alginate [272-274].  Synthetic 
polymers common in tissue engineering research are polyglycolic acid (PGA) [275-
278], polylactic acid (PLA) [279-281], poly(lactic-co-glycolic acid) (PLGA), poly(ε-
caprolactone) (PCL) [282-284], poly(lactic acid-co-caprolactone) (PLCL) [285-287], 
poly(glycerol-sebacate) (PGS) [288-291], poly(hydroxy butyrate) (PHB) [292,293], 
polyurethane resin (PUR) [183,184,294], and poly(propylene fumarate) (PPF) 
[295,296]. Many of the polymers that have been used in tissue engineering 
applications are biodegradable, including PCL, PLA, PGA, PLGA, PLCL and PGS 
(among others).  Often, one goal of scaffold design and development is to ensure that 
the rate of tissue ingrowth and the rate of polymer biodegradation are well-matched for 
the application at hand.  While the biodegradation kinetics of the polymers listed have 
been examined in depth [32,297-299], the scaffold fabrication between the various 
polymeric materials has been widely varied.  In addition, the analytical methods for 
examining biodegradation are not always consistent between studies.  
In this study, four polymers common in biomedical applications were examined 
(Figure 60): PGS, PLA/PCL blend, PLGA (all biodegradable at different rates), and a 
segmented PUR (not biodegradable). To illustrate the broad usage of these polymers in 
biomedical research, we have briefly reviewed each in the paragraphs below. 
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Figure 60: Chemical structures of polymers used in study. 
 
PGS is a bioresorbable elastomer developed by Wang et al. in 2002 [300].  PGS 
has tunable mechanical properties, which makes it particularly interesting in tissue 
engineering applications.  The elastic modulus and ultimate tensile strength can range 
from 0.056 to 1.20 MPa, and 0.23 to 0.47 MPa, respectively, depending on cure 
temperature [301].  PGS degrades rapidly by surface erosion, which results in a linear 
mass degradation profile [298], regardless of degradation media composition [300,301].  
PGS has a short, but very rich history as a biomaterial, in vivo and in vitro [289,302-
304], including uses in nerve guides [305] and heart valve constructs [306].  PGS has 
been fabricated using a number of technologies [288-291,303,304,306-309], resulting in 
both porous and nonporous formats.  However, while the degradation kinetics of 
nonporous PGS have been examined [298,300,301,305,310], degradation kinetics of 
porous PGS have not yet been published. 
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PCL and PLA are commonly prepared as a blend or a copolymer. PCL is a semi-
crystalline aliphatic polyester with a relatively long degradation time (2 years), due to 
its hydrophobicity and crystallinity [311].  PLA is an aliphatic polyester that degrades in 
2-24 months [312,313].  PLA is available in both the L and D stereoisomer forms, 
which affects the degradation rate, crystallinity, and molecular weight [314].  PLA/PCL 
blends and copolymers undergo bulk degradation by hydrolysis [312,315-317].  
PLA/PCL blends have been used in a variety of ways, including drug delivery [318-
321] and for nerve repair [322,323].  However, biodegradation of PLA/PCL blends in a 
porous format has not yet been examined.  
PLGA, a copolymer of PLA and PGA, is another commonly used biodegradable 
polymer [32,189,324-333].  PGA is a crystalline aliphatic polymer that rapidly degrades 
(2-12 months) because of its hydrophilic nature [313,334]. PLGA has a degradation 
time of 1-6 months, based on the PLA/PGA ratio, as well as the crystallinity and 
molecular weight [313], with a 50/50 copolymer having the most rapid degradation rate 
[335].  Degradation studies have also been done on PLGA porous foams in vitro, 
commonly in PBS [32,331-333], and in vivo [32].  While many in vitro and in vivo 
studies have already been performed on PLGA, the degradation rate is highly reliant on 
the format (porous vs. nonporous), the ratio of PLA to PGA, and the starting molecular 
weight, making more research in this area crucial for understanding the potential uses of 
PLGA in biomedical applications. 
PURs have been used in many biomedical applications [183,184,294,336-338], 
including pacemaker lead insulation and catheters [182].  While traditionally known as 
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non-biodegradable, PURs are susceptible to environmental stress cracking [339].  The 
elastomeric properties of PUR make it a potentially useful platform in soft tissue 
engineering [183,184,294].  The polyether PUR used in this study is Texin 950, a 
segmented block copolymer.  Segmented PURs are made up of soft segments (usually a 
polyol) and hard segments (a diisocyanate and chain extender) and can be tailored to 
have a wide range of mechanical properties.  In vivo degradation studies have been 
performed on chemically similar PURs (based on MDI, 1,4-butanediol, and 
poly(tetramethylene) ether glycol) [340,341] but to our knowledge, Texin 950 has not 
been the subject of inquiry.  In this study, we examine the in vitro biodegradation of 
Texin 950 in a porous format, presenting data that is currently not available in the 
literature.  
This study compares four polymers relevant to tissue engineering, and presents 
the first biodegradation study of porous PGS, porous PLA/PCL blend, and porous PUR.  
While most tissue engineering scaffolds have a porous structure, many biodegradation 
studies do not reflect this fact.  We focused our efforts on salt-leached porous scaffolds 
with a nominal pore size of approximately 200 µm.  We performed a biodegradation 
analysis in simulated body fluid (SBF), under aseptic, 37°C conditions.  The polymers 
were analyzed at specific intervals over a time course of 16 weeks, using a variety of 
techniques to examine chemical, thermal, mechanical, and structural changes. Our 
results indicate that the PGS, PLA/PCL blend, and PLGA undergo significant chemical 
changes indicative of biodegradation, in time periods as little as 2-4 weeks.  In addition, 
PUR, as a non-biodegradable polymer, exhibits cracking over time, leading to altered 
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mechanical properties, which may impact the success of this polymer in a biomedical 
application.  These factors are critical when considering material choice, fabrication 
technique, and ultimately cell integration with a biomedical device, and therefore need 
to be studied in a systematic fashion, as described herein. 
 
5.3. Experimental Details 
5.3.1. Materials 
 PUR (Texin 950) was obtained from Bayer MaterialScience (Pittsburgh, PA).  
PLA 3051D was purchased from Natureworks (Minnetonka, MN).  PCL, glycerol, 
sebacic acid, and dimethyl sulfoxide (DMSO) were acquired from Sigma Aldrich.  
Glycolic acid was from TCI America (Portland, OR).  Chloroform was purchased from 
VWR (West Chester, PA).  Tetrahydrofuran (THF) and 1,1,1,3,3,3-
hexamethyldisilazane (HMDS) were from Acros Organics (Morris Plains, NJ).  Sodium 
chloride (NaCl) was purchased from EMD Chemicals Inc. (Gibbstown, NJ). Zinc 
acetate dihydrate (Zn(CH3CO2)2·2H2O(I)) was obtained from Strem Chemicals 
(Newburyport, MA).   
5.3.2. Polymer/polymer blend synthesis  
 The PGS pre-polymer synthesis was adapted from established methods [300].  
Briefly, equimolar (1:1) amounts of anhydrous glycerol, and sebacic acid, which was 
purified via recrystallization in ethanol (3 times), were mixed in an airtight glass jar that 
was partially immersed in a heated silicone bath. The mixture was gradually heated to 
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120 ºC under nitrogen gas flow. The mixture was then stirred with a rotor (50 rpm) at 
this temperature for 24 h. The gas flow was then stopped and vacuum was applied at –
20 kPa for a further 24 h.   
PGA was synthesized by polycondensation, with zinc acetate dihydrate as the 
catalyst, as previously established [342].  This method produces a high molecular 
weight PGA with a number average molecular weight (Mn) of 45,000, a weight average 
molecular weight (Mw) of 91,000, and a crystallinity of 33%, as reported by Takahashi 
et al [342].   
PLGA (PLA/PGA 85:15) copolymer and PLA/PCL (50:50) blend were prepared 
using microwave radiation [188].  Briefly, polymers were dissolved (or suspended) in 
chloroform at 10% (w/v).  The respective polymers were mixed prior to microwaving.  
This method produced a PLA/PCL blend with a PCL continuous phase and PLA 
microspheres ranging in diameter from 0.5-1 mm.    
5.3.3. Preparation of specimens 
 The porous specimens were prepared by a solvent casting/salt leaching method 
[189,290].  Polymers were dissolved in solvent to yield a solution of 5% (w/v).  
Chloroform was used as the solvent for PLGA and PLA/PCL blend.  The solvent used 
for PUR and PGS was THF.  NaCl particles (>125μm) (90% w/v) were added to each 
solution.  The solution was cast into rectangular molds (45 x 13 x 3 mm).  The 
specimens were air-dried for 48 h to allow the solvent to evaporate.  The PGS 
specimens were then cured at 120˚C for 7 days.  The specimens were subsequently 
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removed from the mold and immersed in distilled deionized water at 60˚C for 72 h to 
leach out the salt.     
5.3.4. In vitro degradation 
SBF was prepared by dissolving various reagents in ddH20 at 37°C [343].  The 
SBF was filtered (0.2µm) for sterility.  Porous polymer specimens (45 x 13 x 3 mm) 
were soaked in SBF and incubated in a controlled environment (37°C, 5% CO2).  Every 
two weeks, three specimens were removed from SBF.  The surface liquid was removed 
with a Kimwipe, and the surfaces were air dried overnight in a laminar flow hood to 
maintain sterility.  The degradation study lasted for sixteen weeks, a time period 
suitable for comparing polymers with variable degradation rates.     
5.3.5. Porosity of the initial samples 
 The porosity was calculated using the densities of the porous and non-porous 
polymers.  Ten specimens were used for porosity calculations.  The densities of the 
porous scaffolds were measured using a pycnometer.  The scaffolds were dried at 70°C 
for 1 h prior to measurements.  First, the empty, dry pycnometer was weighed (m0).  A 
scaffold was inserted into the pycnometer and the weight was taken again (ma,dry). After 
that, the scaffold was then soaked in distilled water and placed back into the 
pycnometer and measured again (mb,wet). Distilled water was added so that the 
pycnometer was filled.  The total weight was taken (m2).  The pycnometer was emptied 
and filled again with just distilled water (m3). The difference between the weight of the 
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material wet versus dry was taken (d = mb,wet –ma,dry) then added to the weight of only 
distilled water in the pycnometer (m3,corrected = m3 +d).  The weight of the water (mH2O = 
m3,corrected – m0) and the weight of the scaffold (mS = ma,dry- m0) were calculated.  Then 
the weight of the added water was calculated (m′H2O = m2 - ma,dry).  The volume of the 
scaffold (VS) was calculated using the following equation: 
                                                   
         
 
    
                                                (35) 
The density of the scaffold, ρS, was then calculated using the equation below: 
                                                                   
  
  
                                                         (36) 
Finally, the porosity was calculated using the density of the nonporous polymer (ρP) 
and the density of the porous scaffold: 
                                                       
     
  
                                             (37) 
5.3.6. SEM 
SEM was conducted using a Philips XL30 ESEM. The parameters used are as 
indicated at the bottom of each SEM image.  Prior to imaging, the samples were sputter 
coated with iridium using an EMS575x Turbo Sputter Coater, using a sputter current of 
20 mA for 30 seconds. 
5.3.7. Mechanical testing: compression tests 
Compression testing is a common method for analyzing mechanical properties 
of porous biomedical polymers [344-346].  It has been used to evaluate biodegradation 
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of porous PLGA [347].  Testing was performed using a Rheometrics ARES System in 
compression mode at a cross-head speed of 0.083 mm/s.  Porous specimens were cut 
into 3 mm cubes for testing.   The compressive modulus was calculated as the slope of 
the initial linear portion of the stress-strain curve.  Ten compression tests were 
performed for each time point.   
5.3.8. Attenuated total reflectance-Fourier transform infrared spectroscopy 
(ATR-FTIR) 
ATR-FTIR was performed on a Perkin Elmer Spectrum 100.  The FTIR 
absorbance spectra were obtained with 16 scans per sample over the range of 4000–650 
cm
-1
, with a resolution of 4 cm
-1
.  Three samples were used for each time point. 
5.3.9. GPC 
GPC was performed on a Waters Associates Liquid Chromatography machine 
(Model #201, Milford, MA).  Polymers were dissolved in THF to form 1% (w/v) 
solutions.  The Mn and Mw data were expressed with respect to polystyrene standards.  
Three samples were used for each time point.   
5.3.10. DSC 
DSC was used to monitor thermally induced polymer processes.  It was carried 
out on a DuPont DSC2910 at a rate of 10°C/min; each sample was re-heated.  Samples 
weighed approximately 15mg.  The polymer samples were heated based on the areas of 
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interest for each polymer.  PGS samples were heated from -60°C to 100°C.  PLA/PCL 
blend samples were heated from -60°C to 250°C.  PLGA samples were heated from 
20°C to 250°C.  PUR samples were heated from -40°C to 250°C.  The changes in the 
glass transition temperature (Tg), crystallization temperature (Tc) and melting 
temperature (Tm) were evaluated.   One sample was used for each time point.   
5.3.11. Thermogravimetric analysis (TGA)  
TGA (TA Instruments Q500 Thermogravimetric Analyzer) was used to analyze 
thermal stability.  The onset temperatures, which indicate initial temperature of mass 
loss, were recorded.  A decrease in molecular weight is likely to be reflected in the 
onset temperature.  The specimens were scanned from 30°C to 800°C at a heating rate 
of 10°C/min with a nitrogen flow rate of 40 ml/min.  The weight of each sample was 
approximately 15mg.  Three samples were used for each time point.   
 
5.4. Results and discussion 
5.4.1. Porosity of the specimens 
The porosities of the scaffolds were calculated after determining the densities of 
the porous scaffolds using a pycnometer.  Since the scaffolds were prepared with 90% 
sodium chloride, a porosity of 90% would indicate that all the salt had been leached out.  
However, the calculated porosities of the PGS, PLA/PCL blend, PLGA, and PUR 
scaffolds were 80.06% (±0.02), 83.28% (±0.02), 81.24% (±0.004), and 84.16% (±0.03), 
respectively.  This suggests that some sodium chloride was still present in the scaffolds.   
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5.4.2. SEM 
SEM was used to examine the porous scaffolds during degradation (Figure 61).  
The images confirm that the scaffolds are highly porous, with large pores 
(approximately 200 µm), indicative of the salt-leaching process used to create the 
scaffolds.  The solvent casting/salt leaching method does not give complete 
interconnectivity, but this method is straightforward and simple.  The surface of PGS 
samples no longer exhibited appreciable surface porosity by week 6.  However, the 
cross section showed that the porous structure was still maintained in the core of the 
sample.  These pores disappeared by week 10.  Cracks could be seen on both the surface 
and in the cross section, most likely the result of the shrunken pores.  By week 16, the 
PGS samples became gel-like.  The fast degradation rate of PGS is beneficial for tissue 
engineering, but the loss of surface porosity early during degradation may prevent 
nutrient diffusion to the underlying cells.  In addition, the loss of surface porosity could 
limit diffusion of degradation byproducts out of the scaffolds, possibly leading to toxic 
effects. Therefore, further testing needs to be completed with a PGS/cell hybrid to 
determine if cells maintained deep in the scaffolds are able to survive past the 6 week 
time frame.  
 While the pore structure of the PLA/PCL samples was maintained on the 
surface and throughout the bulk for all 16 weeks, holes and increased roughness can be 
seen starting at week 2 of degradation.  This type of structural change could be 
beneficial in allowing nutrient diffusion into the scaffolds (and degradation byproduct 
117 
 
diffusion out), as well as allowing for cell-cell contact in the bulk of the scaffolds, 
critical to tissue engineering applications. 
On the PLGA samples, cracking can be seen at week 6, and by week 10, large 
cracks are seen on the surface and in the bulk.  Week 16 samples did not have sufficient 
mechanical integrity to allow for SEM preparation and imaging. Similar to the 
PLA/PCL blends, these changes in the structure of scaffold could improve performance 
with regards to cell-cell communication and diffusion.  However, with both the 
PLA/PCL blend and the PLGA, further long-term biodegradation testing with cells 
would be necessary to determine how these structural changes affect cell and tissue-
level integrity. 
The PUR samples seemed to have an increased number of holes by week 8, and 
cracks can be seen by week 10.  This was unexpected, given that PUR is a non-
biodegradable polymer.  However, similar PUR chemistries have been shown to 
undergo significant surface cracking in vivo [341].  While the holes would possibly be 
beneficial for cell integration and diffusion, it is unclear if the structural changes are a 
result of handling or other factors.  Therefore, we chose to examine chemical, thermal 
and mechanical changes that result in each of the polymers chosen. 
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Figure 61: SEM micrographs of polymers at various timepoints of degradation. 
 
5.4.3. Mechanical testing: compression tests 
The compressive modulus of each polymer was examined during the 
degradation study (Figure 62).  Examining the initial compressive modulus indicates 
that some salt may have been left behind in the scaffolds prior to placing in degradation 
buffer.  Therefore, each polymer exhibited a dramatic drop-off in compressive strength 
after the first 2 weeks in culture. Initially, porous PGS had a compressive modulus of 
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7.24±0.93 kPa.  The modulus decreased by approximately 50% at week 6 (3.25±0.61 
kPa), which is attributed to the leaching out of any remaining salt in the scaffold.  The 
modulus increased at week 8 to 7.61±0.89 kPa, which corresponds to the substantial 
loss of porosity (Figure 61) then decreased again at week 10 to 5.53±1.20 kPa.  After 16 
weeks, the PGS samples became gel-like, and therefore, the modulus could not be 
tested.  Wang et al. reported that after 5 weeks in vivo, the compressive modulus of PGS 
implants decreased by 50% [298], similar to the results seen here.   
Porous PLA/PCL blend had an initial compressive modulus of 136.53±34.86 
kPa.  The modulus rapidly decreased, more than 70%, to 36.98±6.28 kPa at week 2, 
likely due to salt leaching.  It further decreased to 11.34±2.55 kPa by week 16.  This 
decrease is significant and could impact the functional ability of the scaffold during cell 
growth.  The macroscopic structure of the scaffold did not appear significantly different, 
indicating that there may not have been significant pore collapse. Therefore, the 
degradation is attributed to bulk degradation [313], which is usually accompanied by a 
rapid loss in mechanical properties, consistent with the results seen here.  
The compressive modulus of the initial porous PLGA sample was 230.39±59.66 
kPa.  From week 0 to week 6, the modulus decreased by 85% to 34.49±5.08 kPa, likely 
due to leftover leached salt.  By week 16, the modulus had decreased to 17.37±3.13 
kPa, a 50% further drop from the week 6 values.  Similar to PLA/PCL, PLGA is known 
to undergo bulk degradation, therefore, the rapid loss of mechanical integrity was 
expected.  In addition, the PLGA macroscopic structure underwent significant changes 
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during the degradation period, indicating a pore breakdown and ultimate collapse of the 
scaffold structure. 
The initial compressive modulus of porous PUR was 28.08±6.00 kPa.  Over the 
course of the degradation study, the modulus decreased more than 30%, to 18.44±3.81 
kPa at week 16.  This was a surprising finding, given that PUR does not undergo 
chemical degradation. However, the loss of mechanical integrity indicates that there are 
other factors at work in PUR incubation, which are further discussed in the data below. 
Regardless, the loss of mechanical integrity indicates that PUR may not be an ideal 
scaffold material for applications requiring a porous structure with continued 
mechanical integrity.  
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Figure 62: Compressive modulus values of a) PGS, b) PLA/PCL blend, c) PLGA, 
and d) PUR.  PGS samples had an increase in compressive modulus from week 6 to 
8, a result of the collapsed pores in the scaffold.  PLA/PCL blend and PLGA had a 
rapid decrease in mechanical strength.  PUR had a more linear decrease in 
compressive modulus.  Error bars represent Standard Error (SE). (*P<0.1, 
**P<0.05, ***P<0.01) 
 
5.4.4. ATR-FTIR 
ATR-FTIR was used to assess chemical changes occurring in the specimens 
during biodegradation.  Each polymer was examined 3 times at each time point and 
averaged.  Specific regions of interest are discussed below. 
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PGS has an intense stretch at approximately 1740 cm
-1
 for the double bond, 
C=O (Figure 63).  The prepolymer displays another peak at approximately 1700 cm
-1
 
for unsaturated carboxylic acids.  As the crosslinks between the PGS strands break 
down, the peak starts to form at 1700 cm
-1
 (noticeably at week 16).  This indicates 
breakdown of crosslinks at week 16.   
 
 
 
Figure 63: ATR-FTIR C=O stretch in PGS as a function of degradation time. 
 
PLA/PCL blend, prior to degradation, exhibits C=O stretching at 1750 cm
-1
 (due 
to PLA rich phase) and 1728 (due to PCL rich phase) (Figure 64).  The blend also has 
peaks at 3000 cm
-1
 (due to PLA), 2945 cm
-1
, and 2870 cm
-1
 (due to both PLA and PCL), 
representing the alkyl groups [348].  As the PLA/PCL blend degrades, the peaks due to 
the alkyl vibrations are maintained.  A new peak forms at 3200 cm
-1
, likely due to the 
increase in O-H groups as the polymer chains break.  In addition, the C=O stretch 
exhibits an increase in the peak absorbance associated with the PLA and PCL.  At week 
16, the PLA/PCL blend C=O vibrational stretch indicates the evolution of increased free 
PLA and PCL.  However, the slight shift of the peak near 1750 cm
-1
 indicates 
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noncovalent interactions between the molecules as the polymer undergoes 
biodegradation. 
 
 
 
Figure 64: ATR-FTIR regions of interest for PLA/PCL blend as a function of 
degradation time. 
 
PLGA FTIR spectra can be seen in Figure 65.  During the first 6 weeks of 
PLGA degradation, a broad peak forms at 3400 cm
-1
, indicating an increase in hydroxyl 
groups because of chain scission [349].  By week 10, the peak shifts to 3200 cm
-1
.  This 
indicates a decrease in hydroxyl groups, as the soluble hydroxyl end groups are leached 
out of the polymer. Likewise, the peak at 1750 cm
-1
, which represents the C=O bond, 
increases from week 0 to 6, as chain scission occurs and carboxylic acid groups are 
formed.  It then decreases from week 6 to 10, indicating that the carboxylic acids are 
being leached out, which results in significant mass loss [349].  From week 10 to 16 the 
C=O bond increases, most likely the result of more chain scission.   
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Figure 65: ATR-FTIR regions of interest for PLGA as a function of degradation 
time. 
 
PUR has peaks at 2855 cm
-1
 and 2941 cm
-1
 for the C-H stretch (Figure 66).  It 
also displays peaks at 1700 cm
-1
 and 1733 cm
-1
 for the C=O bond.   No significant 
changes were seen in the C-H and C=O stretches of PUR, indicating no major changes 
are occurring to the chemical bonding structure of the polymer.  PUR, an MDI-based 
polyurethane, has semicrystalline hard segments which generally protect the urethane 
linkages [340]. 
 
 
 
Figure 66: ATR-FTIR spectral regions for PUR as a function of degradation time. 
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5.4.5. GPC 
The molecular weights and polydispersity index (PDI) of the polymer samples 
were analyzed using GPC.  In specimens that undergo bulk degradation (PLGA and 
PLA/PCL), a reduction in molecular weight is indicative of degradation in the absence 
of bulk weight loss. All results can be seen in Table 5.  For the PGS samples, only the 
prepolymer and week 16 were analyzed by GPC, due to the cross-linked nature of cured 
PGS. PGS samples through week 10 would not dissolve in THF, but the week 16 
samples did dissolve, confirming that the crosslinks had entirely broken down.  
Additionally, the Mn and Mw decreased 14% and 12%, respectively, indicating that 
polymer chain length decreased compared to the prepolymer.   
Because PLA/PCL is a polymer blend, two distinct peaks were expected.  
However, the starting molecular weights of the two polymers are similar: the Mn and 
Mw of PLA are 80,000 and 125,000, and the Mn and Mw of PCL are 84,000 and 
119,000, respectively, as measured by GPC.  Consequently, only one broad peak was 
found for all samples, consistent with Zhang et al.’s findings [115].  This peak became 
broader over the course of the biodegradation study, which is reflected in the increase in 
the PDI.  Because only one peak was observed for the blend, the PDI does not 
distinguish between the two polymers and is intended to be an approximation.  It is 
hypothesized that if the biodegradation study had been carried out longer, eventually 
two peaks would have become evident, as PLA is known to degrade faster than PCL.  
Overall, the Mn and Mw of the PLA/PCL blend decreased 45% and 29%, respectively, 
in the 16 week study. 
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The PLGA samples experienced a rapid decrease in Mn and Mw of 53% and 
75%, respectively, by week 2.  By week 16, the Mn and Mw had decreased 92% and 
97%, respectively, from the initial samples.  Interestingly, the PDI decreased throughout 
the experiment to a value of 1.00 by week 16, indicating that polymer chain scission 
had occurred very uniformly. 
 The PUR samples did not exhibit any decreases in Mn and Mw after 16 weeks, 
and the small variations seen are considered to be within the expected GPC error range 
of <10%.  This was an expected result, given the known properties of PUR; however, it 
does not help to explain the loss of compressive strength that was observed.  
 
Table 5: Change in molecular weight for polymer samples. 
 
PGS PLA/PCL blend 
Week Mn  Mw  PDI Week Mn  Mw  PDI 
Prepolymer 600 2500 4.17 0 92,900 174,000 1.87 
16 500 2200 4.40 4 86,300 166,500 1.93 
    8 76,200 160,300 2.10 
    16 51,200 123,000 2.40 
PLGA PUR 
Week Mn  Mw PDI Week Mn Mw  PDI 
0 17,900 51,200 2.86 0 77,000 235,300 3.06 
2 8300 12,900 1.55 8 79,600 221,200 2.78 
10 1600 1600 1.00 10 79,600 227,700 2.86 
16 1400 1400 1.00 16 81,600 237,400 2.91 
  
5.4.6. DSC 
The thermal properties of the polymer samples were analyzed using DSC.  All 
Tg, Tm, and Tc values can be seen in Table 6.  All PGS samples have a Tg of 
approximately -30ºC [350].  The prepolymer displays one melting temperature (Tm = 
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10ºC) and one crystallization temperature (Tc = -18ºC), as does the week 0 sample (Tm 
= 1ºC, Tm = -21ºC).  At week 8, another melting peak is observed at 32ºC.  By week 16, 
three melting peaks are evident, at 2 ºC, 33ºC, and 75ºC.  These additional peaks are 
attributed to the breakdown of PGS into its monomers, consistent with the ATR-FTIR 
and GPC data.   
The Tg of PCL has been reported to be approximately -60°C [351], while the Tg 
of PLA was measured as 51°C.  No discernible Tg was observed in the PLA/PCL blend 
samples.  However, the samples display two distinct melting regions, one at 
approximately 60°C for the PCL regions, and another at approximately 155°C, for the 
PLA regions, which is consistent with other reports [352-354].  An interesting finding is 
that the week 0 samples display one broad endotherm at 154°C for the melting of the 
PLA regions, while weeks 4, 8, and 16 display two endothermic peaks at approximately 
150°C and 155°C, possibly indicating microphase separation.  The PLA/PCL blend 
samples also display two distinct recrystallization temperatures, one at approximately 
30°C for the PCL regions, and another at approximately 120°C for the PLA regions.  
The presence of two distinct melting and recrystallization regions confirm that 
PLA/PCL is a polymer blend.   
Only one melting and crystallization region is observed in the PLGA DSC 
results, confirming that PLGA is a copolymer. Large decreases in the Tg, Tc, and Tm of 
PLGA can be seen by week 10.  These observations confirm the chain scission that 
occurs during degradation, which results in increased chain mobility [355], and is 
consistent with the GPC and ATR-FTIR results. 
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The glass transition temperature of the PUR samples is not easily discernable.  
PUR has endotherms at approximately 180ºC and 200 ºC.  Hiltz reported that the 
endotherm at 180ºC indicates the presence of microcrystalline hard segments, while the 
endotherm at 200ºC is due to melting of crystalline hard segments resulting from 
increased phase separation [356].  From week 0 to week 4, the melting and 
crystallization temperatures shifted to the right, suggesting that the microcrystalline 
hard segments may have become slightly more ordered [356].   
 
Table 6: Changes in thermal properties of polymers during degradation (PP = 
prepolymer). 
 
PGS PLA/PCL blend 
Week Tm1  
(°C) 
Tm2 
(°C) 
Tm3 
(°C) 
Tc 
(°C) 
Week Tm1 
(°C) 
Tm2 
(°C) 
Tm3 
(°C) 
Tc1 
(°C) 
Tc2 
(°C) 
PP 10 - - -18 0 60 - 154 31 123 
0 1 - - -21 4 58 148 154 27 118 
8 4 32 - -22 8 60 150 156 27 119 
16 2 33 75 -13 16 58 147 155 30 117 
PLGA PUR 
Week 
Tg  
(°C) 
Tc  
(°C) 
Tm  
(°C) 
Week Tm1  
(°C) 
Tm2  
(°C) 
Tc  
(°C) 
0 52 118 148 0 178 187 117 
2 53 113 151 4 184 203 151 
10 38 103 136 10 188 200 150 
16 39 99 129 16 184 199 155 
 
5.4.7. TGA 
Thermal stability was evaluated by TGA (Figure 67).  As biodegradation occurs, 
thermal stability decreases, which is reflected in the onset temperature.  The high 
weight percentage at the end of the test for the week 0 samples indicates unleached salt 
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present in the samples and residual salt from the SBF.  The onset temperatures, which 
indicate initial temperature of mass loss, can be seen in Table 7.  The onset temperature 
of the PGS prepolymer is 198°C.  The onset temperature increases until week 8, as the 
weight loss curve shifts to the right.  From weeks 8 to 16, the onset temperature 
decreases, as the curve shifts back to the left and more closely matches that of the 
prepolymer.  All onset temperature changes are statistically significant (p<0.01) 
between the weeks analyzed.  The onset temperature of PLGA decreased significantly 
(p<0.01) over the 16 week degradation period by approximately 12%, indicating it 
became less thermally stable as it degraded.  The onset temperature of the PLA/PCL 
blend samples significantly decreased (p<0.05) between weeks 0 and 16 by 
approximately 6%.  No significant decrease of onset temperature was observed for PUR 
over the 16 week degradation period, indicating it maintained its thermal stability. 
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Figure 67: TGA curves of a) PGS, b) PLA/PCL blend, c) PLGA, and d) PUR. 
 
 
Table 7: Changes in thermal stability of polymers during degradation, as indicated 
by onset temperature (To). 
 
PGS PLA/PCL blend PLGA PUR 
Week To (°C) Week To (°C) Week To (°C) Week To (°C) 
0 210 0 312 0 301 0 295 
8 283 2 312 6 277 8 292 
10 257 8 293 10 263 10 295 
16 227 16 294 16 264 16 299 
 
PGS exhibited the fastest biodegradation rate of the 4 polymers tested.  By week 
6, the surface of the samples was no longer porous, and by week 16, the polymer 
became gel-like.  The crosslinks completely disappeared by week 16, marked by the 
appearance of a peak at 1700 cm
-1
.  The Mn and Mw of the prepolymer decreased from 
600 and 2500, respectively, to 500 and 2200, respectively, at week 16.  Additionally, 
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two extra melting peaks were observed at week 16, which indicate monomer presence.  
The rapid degradation rate of PGS and the loss of porosity must be taken into account 
for the chosen application and structure.   
The PLA/PCL blend underwent substantial degradation during the 16 week 
study.  Increased surface roughness was observed by SEM, starting at week 2.  The Mn 
and Mw decreased 45% and 29%, respectively, by week 16.  A drastic decrease in 
compressive modulus of approximately 70% was observed by week 2, which can be 
attributed to bulk degradation and the loss of residual salt.  By week 16, the 
compressive modulus had decreased by approximately 89%.  A new peak at 3200 cm
-1
 
also formed by week 16, which indicates an increase in hydroxyl groups due to chain 
scission.   
 PLGA had a major loss of mechanical integrity and molecular weight during the 
study.    An increase in hydroxyl groups was observed during the first 6 weeks of the 
study, indicating chain scission.  By week 16, the Mn and Mw decreased 92% and 97%.  
PLGA showed decreased thermal stability, as the onset temperature decreased 
approximately 13% by week 16.  Large decreases in the Tg, Tc, and Tm of PLGA were 
also observed.  Like the PLA/PCL blend, the PLGA samples had a drastic decrease of 
compressive modulus initially.  By week 16, the compressive modulus decreased by 
approximately 92%.  The severe loss of mechanical integrity may prevent its use in 
some applications.  
PUR, a nonbiodegradable polymer, had a slight decrease in compressive 
modulus over the 16 week study, which may limit its use for long-term applications.  
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An increased number of surface cracks was also observed by SEM.  A shift in the Tm 
and Tc from weeks 0 to 4 may have signified increased order in the microcrystalline 
hard segments.  However, no changes were observed in the chemical bonds.  No 
decrease in thermal stability was observed.   
5.5. Conclusions 
This study presents a comprehensive, side-by-side analysis of chemical, thermal, 
mechanical, and morphological changes in four polymers used in tissue engineering.  
This study also presents the first report of biodegradation in porous PGS, PLA/PCL 
blend, and PUR.  During the 16 week biodegradation study, all four polymers showed 
signs of degradation.  PGS degraded the quickest, with complete breakdown of its 
crosslinks by week 16.  Additionally, DSC results indicated monomer presence.  Since 
PGS has the fastest degradation rate of the polymers tested, it may be the most 
appropriate for many tissue engineering applications.  However, the fact that the pores 
collapsed after 10 weeks must be taken into consideration.  The PLA/PCL blend quickly 
experienced a rapid decrease in compressive modulus and had significant molecular 
weight decrease.  PLGA degraded more rapidly, with significant chain scission 
occurring in the first 6 weeks, and showed a larger decrease in both compressive 
modulus and molecular weight.  By week 16, the PLGA samples also lost most of their 
mechanical integrity and were difficult to handle.  The rapid loss of mechanical 
properties of the PLA/PCL blend and PLGA copolymer make them unattractive 
candidates for tissue engineering scaffolds.  Cracks and pits were seen in the SEM 
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images of the PUR samples at week 16, which explain the 30% decrease in compressive 
modulus.  However, its molecular weight and thermal stability did not decrease.  PUR 
will not biodegrade in a timely manner, but it also may not be suitable for long-term 
implants, due to the surface flaws that result after long-term incubation.  This 
comprehensive study presents the biodegradation properties of four polymers and can 
serve as a guide for their use in biomedical applications.   
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Chapter 6: Conclusions and Recommendations 
 
6.1. Research Summary 
6.1.1. Effect of In Vitro Aging on Mechanical Properties and Differentiation 
Capacity of Human Mesenchymal Stem Cells 
This study investigated the effect of in vitro aging on the mechanical properties 
of cells, and the relation of the mechanical properties to differentiation ability.  The 
average elastic modulus approximately tripled during extended culture (P4-P11, ~17 
population doublings).  The differentiation capacity seemed reliant of the elastic 
modulus of cells prior to differentiation.  The most successful myogenic differentiation 
occurred when the elastic modulus of the cells matched that of native tissue.  
Osteogenic differentiations were more successful in earlier passages, when the elastic 
modulus of the cells was lower.  While many in vitro aging studies of hMSCs exist, 
this is the first to examine myogenic differentiation in extended culture.  
Furthermore, this investigation is one of the few to look at mRNA expression of lineage 
markers in both undifferentiated and differentiated cells as they age.  These results may 
guide researchers using hMSCs in extended culture. 
 
6.1.2. Mechanical Loading on Polymeric Foams: Effect on hMSC Differentiation 
hMSCs were subjected to cyclic loading to stimulate differentiation in the 
absence of chemical induction.  Cells on PUR and PLA/PCL were stretched (5%, 10%, 
15%, 20%) and compressed (2.5%, 5%, 7.5%, 10%) to induce myogenesis and 
osteogenesis, respectively.  Similar upregulation of myogenic mRNA was observed 
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with 10% stretch and static loading on PUR.  Compressive loading at every condition 
appeared to enhance osteogenesis, with upregulation of Runx2 and Col 1, early 
osteogenic markers.  Loading at 2.5% had the highest upregulation of a late osteogenic 
marker, OC, which may indicate the most mature cells.  This investigation is the first 
that examines cyclic loading of hMSCs in 3-D synthetic scaffolds in the absence of 
chemical induction.  The results of this study indicate that hMSC differentiation can be 
accelerated by mechanical loading.   
 
6.1.3. Cardiogenic Potential of hMSCs by Embryoid Body Formation 
The 3-D cell culture technique of EB formation was used to differentiate hMSCs 
into cardiomyocytes.  The chemical frequently used to induce cardiomyogenic 
differentiation, 5-azacytidine, may also induce non-specific DNA methylation, and 
therefore, may not be a clinical option.  The aligned cells that grew from the EB 
expressed various cardiac protein markers (including MHC, troponin T, and α-actinin).     
Several Z bands, which are indicative or mature sarcomeres, were also observed.  A gap 
junction protein, Cx43, that is necessary for electrical coupling of cardiomyocytes, was 
observed at cell-cell junctions.  This study is the first to examine the mRNA 
expression of cardiomyocytes produced by EB formation, and results show that the 
cells expressed key transcription factors (Nkx2.5, MEF2X, and GATA4).  Given the 
presence of key transcription factors and various cardiomyogenic proteins, EB 
formation may be a viable clinical alternative to chemical induction. 
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6.1.4. In Vitro Comparative Biodegradation Analysis of Salt-Leached Porous 
Polymer Scaffolds 
This biodegradation study presented a comprehensive, side-by-side analysis of 
chemical, thermal, mechanical, and morphological changes in four polymers used in 
tissue engineering: PGS, PLA/PCL blend, PLGA, and PUR.  Frequently these polymers 
are used in a porous format, but the biodegradation rates had not been extensively 
studied.  The four polymers were submerged in simulated body fluid, and examined 
every 2 weeks up to 16 weeks.  Various changes in morphologies, molecular weights, 
and melting and recystallization temperatures were found.  The crosslinks of PGS had 
completely broken down by week 16, and the polymer became gel-like.  Despite being 
marketed as “non-biodegradable,” decreases in compressive modulus values, as well as 
cracks and pitting, were observed for PUR.  This study presented the first report of 
biodegradation in porous PGS, PLA/PCL blend, and PUR, and may guide those 
researchers using these polymers in a porous format for tissue engineering 
applications. 
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6.2. Future Recommendations 
 
6.2.1. Effect of In Vitro Aging on Mechanical Properties and Differentiation 
Capacity of Human Mesenchymal Stem Cells 
While this study gave tremendous insight into the effects of aging on the 
myogenic lineage, the study must be repeated with hMSCs from multiple donors to 
verify the observed trend.  It is also of great interest to see how the change in 
mechanical properties affects the adipogenic and chondrogenic lineages, and how the 
expression of adipogenic/chondrogenic lineage markers change during extended 
culture.  Additionally, the expression of Rho GTPases (RhoA, Rac1, Rock) in aging 
hMSCs should be examined, as these are likely a part of the aging phenomenon.   
 In addition to tracking the changes of hMSCs during extended passaging, efforts 
must be made to prevent this cell aging.  One way to prevent aging may be by culturing 
cells on a softer substrate.  A material of interest is a thermoplastic polyurethane 
(TexinRxT85A) with an elastic modulus of approximately 12.5MPa.  Studies are 
already underway using injection molded PUR samples.  Cell elastic modulus will be 
measured using AFM to see if this material can prevent age-related stiffening. 
 
6.2.2. Mechanical Loading on Polymeric Foams: Effect on hMSC Differentiation 
In the mechanical loading investigation, 3 days of cyclic loading was able to 
upregulate the mRNA of differentiation markers.  This study must be carried out longer 
to examine the protein expression.  Additionally, specific late-stage differentiation 
markers must be observed to deem a differentiation “successful” (i.e. calcium 
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deposition for osteogenesis, which can be assessed by Von Kossa staining- Section 
2.4.6).  Optimization studies may also be done for loading regimen. 
 
 
6.2.3. Cardiogenic Potential of hMSCs by Embryoid Body Formation 
 
The hanging drop method utilized in this study uses 250,000 cells per EB.  More 
studies must be conducted to determine the optimal number of cells per EB.  Other EB 
formation methods may also be investigated, such as hydrogel microwells.  While this 
hanging drop method produces an aligned cell outgrowth that express cardiac proteins, 
other cell types may be present in the actual EB, as is known to be the case with ESC 
EBs.  More work must be done to characterize the cells in the EB.  One obstacle 
associated with hMSC-derived cardiomyocytes is the lack of spontaneous contraction.        
Electrical stimulation may be one way to generate spontaneous contraction, and should 
be investigated.  
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